https://www.novartis.com/us-en/ 2026-05-07T09:50:42-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/victor-bulto 2025-10-22T11:50:24-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/sonia-choi 2025-10-22T11:50:12-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/des-creary 2026-03-06T17:01:15-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/javier-gesualdo 2025-10-22T11:49:43-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/gail-horwood 2025-10-22T11:49:33-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/reshema-kemps-polanco 2026-05-08T15:32:33-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/shefali-kothari 2025-10-22T11:49:09-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/katie-mazuk 2026-03-06T16:49:04-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/melissa-mckerracher 2025-10-22T11:48:31-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/liviu-niculescu 2025-11-19T14:27:37-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/courtney-piron 2026-01-02T09:41:19-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/vicki-rawlinson 2025-10-22T11:47:53-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/rob-rubinsky 2025-10-22T11:47:42-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/eden-wells 2025-11-17T13:55:28-05:00 daily 1.0 https://www.novartis.com/us-en/robert-stanley 2026-05-08T14:47:44-04:00 daily 1.0 https://www.novartis.com/us-en/page-not-found 2022-03-30T01:06:54-04:00 daily 1.0 https://www.novartis.com/us-en/news/news-archive 2024-03-26T10:29:49-04:00 daily 1.0 https://www.novartis.com/us-en/careers 2026-03-05T14:26:50-05:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/novartis-commitment-patients-and-caregivers 2025-04-25T14:06:51-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior 2024-03-26T09:33:56-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/code-ethics 2025-10-06T10:48:38-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/speakup 2025-12-17T17:25:45-05:00 daily 1.0 https://www.novartis.com/us-en/terms-use 2024-03-27T09:34:26-04:00 daily 1.0 https://www.novartis.com/us-en/careers/awards-recognition 2025-02-08T23:18:05-05:00 daily 1.0 https://www.novartis.com/us-en/careers/employee-benefits 2025-04-25T13:56:35-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/novartis-patient-support 2025-11-11T11:56:34-05:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/people-and-communities 2024-03-26T10:15:18-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/business-principles 2024-03-26T09:42:26-04:00 daily 1.0 https://www.novartis.com/us-en/esg/environmental-sustainability 2025-01-29T11:43:09-05:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/compliance-program 2025-07-02T09:57:58-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws 2025-06-25T11:51:17-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/phrma-code-interactions-healthcare-professionals 2024-03-26T09:39:51-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/payments-hcps-hcos 2022-03-28T12:02:01-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/patient-assistance-foundation-enrollment 2024-09-30T17:26:40-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/ca-health-and-safety-code-ss119402 2025-06-25T11:51:37-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/annual-description-comprehensive-compliance-program 2025-06-25T11:52:03-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/california-npc-declaration-compliance 2025-06-25T11:52:22-04:00 daily 1.0 https://www.novartis.com/us-en/news/us-media-contacts 2025-01-08T13:48:58-05:00 daily 1.0 https://www.novartis.com/us-en/contact-select 2025-10-17T12:16:10-04:00 daily 1.0 https://www.novartis.com/us-en/careers/nibr-careers-frequently-asked-questions 2022-03-13T11:21:01-04:00 daily 1.0 https://www.novartis.com/us-en/recall-zofran-and-entresto-packages 2025-01-30T03:47:16-05:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/drug-supply-chain-security-act-information 2025-01-30T03:49:14-05:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/novartis-society-integrated-report 2025-02-10T10:01:00-05:00 daily 1.0 https://www.novartis.com/us-en/about/novartis-us/company-glance/value-and-pricing 2022-03-28T12:51:24-04:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/novartis-us-foundation 2022-03-28T13:05:34-04:00 daily 1.0 https://www.novartis.com/us-en/about/novartis-us/our-commitment-patients-caregivers 2022-03-25T09:37:33-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance 2025-04-25T14:04:43-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding-healthcare-professionals 2025-04-25T14:02:42-04:00 daily 1.0 https://www.novartis.com/us-en/about/external-funding/educational-grants 2022-05-17T11:18:02-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/sponsorships-and-memberships 2026-05-13T13:35:20-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/faqs 2025-03-05T11:40:10-05:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/educational-grants/professional-medical-education-grants 2026-05-13T17:45:59-04:00 daily 1.0 https://www.novartis.com/us-en/about/external-funding/educational-grants/patient-education-grants 2022-05-17T11:27:15-04:00 daily 1.0 https://www.novartis.com/us-en/about/inclusion-and-belonging/supplier-innovation-development 2026-02-04T13:07:58-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-research 2024-10-29T03:05:19-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-digital 2025-01-24T09:37:59-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-information-technology-it 2025-01-24T09:40:08-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-procurement 2024-10-29T03:06:16-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-health-safety-environment 2024-10-29T03:07:09-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-medical-development 2025-01-24T09:38:36-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-people-organization 2025-01-24T09:38:47-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-communications-and-advocacy 2022-03-29T03:38:49-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-consulting 2025-01-24T09:39:32-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-technical-operations 2023-11-13T07:49:07-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-strategy 2022-03-29T03:13:12-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-commercial 2024-10-29T03:08:16-04:00 daily 1.0 https://www.novartis.com/us-en/news/step-program/age-related-macular-degeneration-amd 2022-03-28T10:07:02-04:00 daily 1.0 https://www.novartis.com/us-en/careers/early-talent 2025-04-25T13:59:01-04:00 daily 1.0 https://www.novartis.com/us-en/about/contact-us 2025-10-17T12:17:31-04:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/beacon-hope/beacon-hope-solutions-improving-access-healthcare 2025-06-13T11:51:01-04:00 daily 1.0 https://www.novartis.com/us-en/gilenya-guides-community-privacy-policy 2022-07-22T15:01:14-04:00 daily 1.0 https://www.novartis.com/us-en/privacy 2026-04-27T14:14:39-04:00 daily 1.0 https://www.novartis.com/us-en/about/external-funding/educational-grants/professional-medical-education-grants/request-proposal-rfp-paroxysmal-nocturnal-hemoglobinuria-pnh 2023-01-20T12:59:44-05:00 daily 1.0 https://www.novartis.com/us-en/about/external-funding/educational-grants/professional-medical-education-grants/request-proposal-rfp-hyperlipidemia 2023-01-20T12:58:36-05:00 daily 1.0 https://www.novartis.com/us-en/news/radioligand-therapy-supply-information/patient-faqs 2023-06-02T12:52:01-04:00 daily 1.0 https://www.novartis.com/us-en/esg/beacon-hope/paving-way-brighter-more-equitable-future 2024-03-26T10:24:51-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/chronic-spontaneous-urticaria-csu 2025-10-07T14:03:45-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/hidradenitis-suppurativa-hs 2026-03-27T11:29:29-04:00 daily 1.0 https://www.novartis.com/us-en/privacy/consumer-health 2025-10-23T03:52:29-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/prostate-cancer 2026-03-13T13:04:32-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/paroxysmal-nocturnal-hemoglobinuria-pnh 2025-04-25T13:51:44-04:00 daily 1.0 https://www.novartis.com/us-en/external-support-0 2025-09-26T16:54:43-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/breast-cancer 2026-03-13T13:04:13-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/sjogrens-disease 2025-10-21T09:10:27-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team 2026-05-08T14:50:22-04:00 daily 1.0 https://www.novartis.com/us-en/text-message-communications-terms-conditions 2026-01-09T08:54:42-05:00 daily 1.0 https://www.novartis.com/us-en/radioligand-therapy-production-carlsbad-california 2026-05-07T09:56:14-04:00 daily 1.0 https://www.novartis.com/us-en/radioligand-therapy-production-denton-texas 2026-05-14T14:24:25-04:00 daily 1.0 https://www.novartis.com/us-en/biologics-production-14TW-durham-north-carolina 2026-05-07T10:01:26-04:00 daily 1.0 https://www.novartis.com/us-en/gene-therapy-production-tricenter-durham-north-carolina 2026-05-07T10:03:53-04:00 daily 1.0 https://www.novartis.com/us-en/radioligand-therapy-production-indianapolis-indiana 2026-05-07T09:57:40-04:00 daily 1.0 https://www.novartis.com/us-en/radiologand-therapy-production-millburn-new-jersey 2026-05-07T09:59:04-04:00 daily 1.0 https://www.novartis.com/us-en/cell-therapy-production-morris-plains-new-jersey 2026-05-07T10:05:06-04:00 daily 1.0 https://www.novartis.com/us-en/small-molecule-production-morrisville-north-carolina 2026-05-07T10:00:26-04:00 daily 1.0 https://www.novartis.com/us-en/radioligand-therapy-production-winter-park-florida 2026-05-07T10:03:07-04:00 daily 1.0 https://www.novartis.com/us-en/biomedical-research-organization-cambridge-massachusetts 2026-05-07T10:07:49-04:00 daily 1.0 https://www.novartis.com/us-en/biomedical-research-center-san-diego-california 2026-05-07T10:06:00-04:00 daily 1.0 https://www.novartis.com/us-en/news 2026-03-05T15:04:13-05:00 daily 0.5 https://www.novartis.com/us-en/about 2026-03-05T13:01:25-05:00 daily 0.5 https://www.novartis.com/us-en/home 2026-05-07T09:50:42-04:00 daily 0.5 https://www.novartis.com/us-en/esg 2026-03-05T13:14:51-05:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers 2026-03-05T15:06:06-05:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals 2026-03-05T15:02:28-05:00 daily 0.5 https://www.novartis.com/us-en/about/inclusion-and-belonging 2026-02-04T14:39:33-05:00 daily 0.5 https://www.novartis.com/us-en/about/novartis-us 2026-03-05T04:27:14-05:00 daily 0.5 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance 2025-01-30T06:27:39-05:00 daily 0.5 https://www.novartis.com/us-en/esg/corporate-responsibility 2025-02-20T10:41:29-05:00 daily 0.5 https://www.novartis.com/us-en/esg/corporate-responsibility/beacon-hope 2025-06-13T11:49:58-04:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/cardio-renal-metabolism/renal/NCT04181762-us-en 2026-03-05T04:29:45-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/respiratory-allergy/foodallergy/NCT04984876-us-es 2026-03-05T04:43:59-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/SLE/NCT05639114-NCT05624749 2025-06-25T12:18:01-04:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/osteoarthritis/NCT04886258-NCT04814368-NCT05462990-es 2026-03-05T04:45:21-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/RCT/NCT05722522-NCT05758415 2026-03-05T04:46:43-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/LN/NCT05126277 2026-03-05T04:47:56-05:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers/diseases 2026-03-05T04:48:50-05:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers/patient-resources 2026-05-13T13:48:30-04:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals/hcp-resources 2026-03-18T12:49:41-04:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/CINDU/NCT05976243 2025-01-31T11:35:31-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/hematology/ITPWAIHA/NCT05653349-NCT05653219-NCT05648968-us-es 2026-03-05T04:50:11-05:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals/personalized-and-precision-medicine 2026-05-15T11:39:08-04:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals/health-information-technology-resources 2026-03-04T16:11:13-05:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas 2026-03-05T04:51:33-05:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas/oncology 2026-04-07T13:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/about/nfl-partnership 2026-04-23T16:55:11-04:00 daily 0.5 https://www.novartis.com/us-en/about/investing-americas-health 2026-05-07T10:09:54-04:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas/immunology 2026-03-16T17:20:06-04:00 daily 0.5 https://www.novartis.com/us-en/cardiovascular-disease 2026-03-23T16:19:39-04:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas/cardiovascular-renal 2026-03-16T10:55:29-04:00 daily 0.5 https://www.novartis.com/us-en/about/radioligand-therapy 2026-04-09T16:37:04-04:00 daily 0.5 https://www.novartis.com/us-en/kidney-disease 2026-03-16T10:50:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-corrective-action-certain-blister-packages-sandimmune-and-neoral-100-mg-soft-gelatin-capsules-us-due-failure-meet-child-resistant-packaging-requirements 2022-04-04T03:14:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-three-pivotal-trials-showing-durable-and-potent-efficacy-inclisiran-investigational-first-class-sirna-cholesterol-lowering-therapy 2022-04-04T03:09:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-shows-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment 2022-04-04T02:24:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction 2022-03-13T11:20:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-novartis-us-foundation-establish-usd-5-million-us-covid-19-community-response-fund 2022-07-25T11:29:50-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-supports-telehealth-programs-provide-access-care-new-jerseys-most-vulnerable-communities 2022-03-29T04:00:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-met-inhibitor-tabrectatm-metastatic-non-small-cell-lung-cancer-metex14 2022-03-29T08:12:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-overall-survival-benefit-hrher2-advanced-breast-cancer-consistent-findings-patients-more-aggressive-disease 2022-03-29T03:57:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-underscoring-commitment-advancing-treatment-relapsing-forms-multiple-sclerosis-rms 2022-03-29T08:15:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-treated-tafinlar-mekinist-following-surgery 2022-03-29T08:18:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-fda-approves-updated-novartis-beovu-label-include-additional-safety-information 2022-03-29T08:20:08-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-manufactures-and-donates-27000-units-hand-sanitizer-new-york-state 2022-03-29T08:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis 2022-03-29T08:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ilaris-canakinumab-receives-fda-approval-new-indication-treat-adult-onset-stills-disease-aosd 2022-03-29T08:31:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-entresto-sacubitrilvalsartan-patients-heart-failure-preserved-ejection-fraction-hfpef 2022-03-29T08:34:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-phase-iii-asclepios-trials-demonstrating-superior-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis 2022-03-29T08:00:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-prefilled-syringe-self-administration-across-all-indications 2022-03-29T09:10:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis 2022-03-29T08:38:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-know-podcast-series-hosted-music-icon-cyndi-lauper 2022-03-29T08:39:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-parallax-data-provides-further-evidence-potential-benefit-entresto-patients-hfpef 2022-03-29T08:41:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-shows-high-consistency-lowering-ldl-c-individual-response-investigational-inclisiran 2022-03-29T08:42:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-effects-treatment-mayzent-siponimod-studied-disability-progression-and-cognitive-processing-speed-patients-progressing-relapsing-multiple-sclerosis 2022-03-29T08:43:42-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis 2022-03-29T08:45:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-commits-25m-improve-health-equity-reducing-health-disparities-us 2022-03-29T08:48:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-awards-nearly-375000-patient-advocacy-organizations-their-innovative-solutions-biomarker-testing-now-accepting-proposals-caregiving-cancer-and-certain-blood-disorders 2022-03-29T08:51:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-five-year-data-reinforce-safety-and-efficacy-profile-aimovig-erenumab-aooe-adult-patients-episodic-migraine 2022-03-29T09:07:56-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-early-synovitis-reduction-patients-psoriatic-arthritis-first-its-kind-study 2022-03-29T08:59:08-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-analyses-investigational-inclisiran-demonstrate-consistently-effective-and-sustained-ldl-c-reduction-month-17-regardless-age-and-gender 2022-03-29T09:02:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-data-ash-reinforce-breadth-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases 2022-03-29T09:05:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-adults-nasal-polyps 2022-03-29T09:10:21-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-partner-karamo-brown-support-and-empower-people-living-migraine 2022-03-29T10:13:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-bosulif-chronic-myeloid-leukemia-trial 2022-03-29T10:09:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer 2022-03-29T10:15:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-fda-advisory-committee-recommendation-use-entresto-treat-patients-hfpef 2022-03-29T10:37:59-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ligelizumab-qge031-receives-fda-breakthrough-therapy-designation-patients-chronic-idiopathic-urticaria-ciu 2022-03-29T10:34:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda 2022-07-25T11:38:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-awards-450000-eight-nonprofit-organizations-through-step-programtm 2022-03-29T10:48:05-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-xolair-omalizumab-self-injection-prefilled-syringe-across-all-indications-appropriate-patients 2022-03-29T10:50:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-aan-novel-combination-biomarker-may-predict-disability-worsening-secondary-progressive-multiple-sclerosis 2022-03-29T10:54:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kesimpta-ofatumumab-data-aan-showed-reduction-disability-progression-independent-relapse-activity-newly-diagnosed-patients-rms 2022-03-29T11:00:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-data-aad-vmx-shows-improvement-skin-symptoms-and-quality-life-was-maintained-one-year-children-moderate-severe-plaque-psoriasis 2022-03-29T11:00:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-beovu-data-show-potential-fluid-resolution-more-diabetic-macular-edema-patients-fewer-injections-versus-aflibercept 2022-03-29T11:06:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-commits-addressing-racial-disparities-breast-cancer-screening-treatment-and-care 2022-03-29T11:05:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program 2022-03-29T10:09:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis 2022-03-29T10:09:26-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates-and-remarkable-safety-profile-relapsed-or-refractory-follicular-lymphoma 2022-03-29T10:08:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reports-longest-median-overall-survival-postmenopausal-hrher2-metastatic-breast-cancer-patients 2022-03-29T10:08:44-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-checkpoint-inhibitor-tislelizumab-met-primary-endpoint-overall-survival-pivotal-phase-iii-trial-esophageal-cancer-after-systemic-therapy 2022-03-29T10:08:02-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc 2022-03-29T10:07:50-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges-universities-medical-schools-and-other-leading-organizations-co-create-effective-measurable-solutions-health-equity 2022-03-29T10:19:17-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-results-from-phase-iii-trials-beovu-diabetic-macular-edema-including-dosing-intervals-16-weeks 2022-03-29T10:16:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-meet-pros-raise-awareness-and-support-education-pik3ca-related-overgrowth-spectrum-pros 2022-03-29T10:31:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-findings-from-real-world-study-alpelisib-demonstrating-clinical-benefit-people-pik3ca-related-overgrowth-spectrum-pros 2022-03-29T10:34:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-kisqali-data-showing-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer 2022-03-29T10:38:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-and-ema-filing-acceptances-beovu-patients-diabetic-macular-edema 2022-03-29T10:58:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kesimpta-ofatumumab-data-ectrims-highlights-preservation-igg-levels-and-safety-experience-over-extended-exposure-35-years-people-living-relapsing-multiple-sclerosis 2022-03-29T11:02:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-scemblix-asciminib-novel-mechanism-action-treatment-chronic-myeloid-leukemia 2022-03-29T11:09:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-iptacopan-meets-primary-endpoints-phase-ii-study-rare-kidney-disease-c3-glomerulopathy-c3g 2022-03-29T11:13:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-positive-phase-iii-results-cosentyx-children-active-enthesitis-related-arthritis-era-and-juvenile-psoriatic-arthritis-jpsa-acr-2021 2022-03-29T11:20:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-kisqali-data-shows-consistent-overall-survival-benefit-across-genomic-and-clinical-subtypes-interest-hrher2-metastatic-breast-cancer 2022-03-29T11:27:32-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-highlight-efficacy-piqray-hrher2-metastatic-breast-cancer-pik3ca-driver-mutation-immediately-post-cdk46i 2022-03-29T11:32:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-strong-responses-high-risk-patients-relapsed-or-refractory-follicular-lymphoma-extended-study-follow 2022-03-29T11:37:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-t-chargetm-next-generation-car-t-platform-first-human-data-ash-2021 2022-03-29T11:33:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-leqvio-inclisiran-first-class-sirna-lower-cholesterol-and-keep-it-low-two-doses-year 2022-07-21T12:09:56-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-enthesitis-related-arthritis-and-psoriatic-arthritis 2022-03-29T11:25:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study 2022-03-29T11:20:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma 2022-07-07T10:23:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-vijoice-alpelisib-first-and-only-treatment-select-patients-pik3ca-related-overgrowth-spectrum-pros 2022-07-07T10:23:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer 2022-07-07T10:23:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study-0 2022-07-07T10:23:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment 2022-07-07T10:24:24-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-met-inhibitor-capmatinib-inc280-first-potential-treatment-metex14-mutated-advanced-non-small-cell-lung-cancer-granted-priority-fda-review 2022-07-07T10:24:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/public-private-collaboration-commits-accelerate-access-health-services-africa-reaching-17-million-people 2022-07-07T10:24:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps 2022-07-07T10:24:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-us-patients-when-used-real-world-setting 2022-07-07T10:24:30-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-medicine-adakveo-crizanlizumab-tmca-approved-fda-reduce-frequency-pain-crises-individuals-living-sickle-cell-disease 2022-07-07T10:24:30-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-work-music-icon-cyndi-lauper-bring-life-impact-psoriasis-can-have-workplace 2022-07-07T10:24:30-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-now-accepting-submissions-proposals-address-unmet-patient-needs-cancer-biomarker-testing 2022-07-07T10:24:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept 2022-07-07T10:24:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum 2022-07-07T10:24:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presents-new-data-epns-continuing-show-significant-therapeutic-benefit-zolgensma-prolonging-event-free-survival-now-5-years-age-patients-spinal-muscular-atrophy-sma-type-1 2022-07-07T10:24:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/entresto-improved-measures-heart-structure-and-function-hfref-patients-new-novartis-study-additional-data-complement-findings 2022-07-07T10:24:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-celebrity-interior-designer-nate-berkus-launch-my-home-sight-program-empowering-people-wet-amd-live-more-independently-home 2022-07-07T10:24:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-file-and-accelerates-review-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101 2022-07-07T10:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-offers-free-genetic-mutation-testing-program-advanced-melanoma-patients-results-can-help-doctors-and-patients-making-cancer-treatment-decisions 2022-07-07T10:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/long-term-survival-benefit-shown-metastatic-melanoma-patients-treated-novartis-tafinlar-mekinist 2022-07-07T10:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-shows-growing-strength-lung-cancer-innovation-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials 2022-07-07T10:24:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families 2022-07-07T10:24:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma 2022-07-07T10:24:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-demonstrate-novel-approaches-reimagining-medicine-cancer-and-serious-blood-disorders 2022-07-07T10:24:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/five-nonprofit-organizations-receive-250000-through-novartis-step-programtm-support-sickle-cell-patient-initiatives 2022-07-07T10:24:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-promacta-125-mg-oral-suspension-due-potential-peanut-contamination 2022-07-07T10:24:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-avexis-data-aan-showed-long-term-durability-zolgensma-patients-spinal-muscular-atrophy-sma-type-1 2022-07-07T10:24:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presented-robust-data-aan-demonstrating-efficacy-zolgensma-broad-spectrum-spinal-muscular-atrophy-sma-patients 2022-07-07T10:24:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd 2022-07-07T10:24:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-purchase-advanced-biologics-therapy-manufacturing-campus-longmont-colorado 2022-07-07T10:24:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease 2022-07-07T10:24:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-further-support-initiation-entresto-hospital-and-first-choice-systolic-heart-failure-therapy-stabilized-patients 2022-07-07T10:24:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-psoriasis-patients-treated-cosentyx-reported-improvements-quality-life-measures-early-week-4 2022-07-07T10:24:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation-prevention-vaso-occlusive-crises-sickle-cell-disease 2022-07-07T10:24:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-demonstrates-consistent-efficacy-and-tolerability-kisqali-combination-therapy-hrher2-advanced-breast-cancer-patients-difficult-treat-visceral-disease 2022-07-07T10:24:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-consistently-improved-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-new-solar-1-analyses 2022-07-07T10:24:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies 2022-07-07T10:24:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-longer-term-analyses-from-pivotal-kymriah-trials-showed-durable-responses-are-maintained-patients-advanced-blood-cancers 2022-07-07T10:24:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-crizanlizumab-seg101-data-analysis-sickle-cell-disease-and-investment-sentry-clinical-program 2022-07-07T10:24:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication 2022-07-07T10:24:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-fund-five-innovative-ideas-support-patients-and-sickle-cell-community 2022-07-07T10:24:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-study-supports-entresto-foundational-hfref-therapy-and-hospital-initiation-appropriate-stabilized-heart-failure-patients 2022-07-07T10:25:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-ash-and-sabcs-show-strength-pipeline-and-portfolio-hematology-and-oncology 2022-07-07T10:25:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-wins-esteemed-prix-galien-foundation-best-biotechnology-product-award-car-t-cell-therapy-kymriah 2022-07-07T10:25:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-year-data-novartis-brolucizumab-reaffirm-superiority-versus-aflibercept-reducing-retinal-fluid-patients-namd 2022-07-07T10:25:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-cosentyx-data-demonstrating-long-term-response-and-safety-ankylosing-spondylitis 2022-07-07T10:25:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-analysis-shows-crizanlizumab-seg101-increased-number-patients-free-sickle-cell-pain-crises-vs-placebo-during-sustain-study 2022-07-07T10:25:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-siponimod-baf312-first-and-only-oral-drug-shown-delay-disability-progression-typical-spms-patients 2022-07-07T10:25:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-recording-artist-and-actress-jordin-sparks-and-scdaa-launch-generation-s-inspiring-new-sickle-cell-storytelling-project 2022-07-07T10:25:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-landmark-paradigms-study-demonstrating-significant-benefit-gilenya-children-and-adolescents-relapsing-multiple-sclerosis 2022-07-07T10:25:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-now-first-and-only-cdk46-inhibitor-indicated-us-first-line-therapy-specifically-premenopausal-women-and-initial-therapy-fulvestrant-postmenopausal-women 2022-07-07T10:25:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-galaxies-hope-app-digital-experience-neuroendocrine-tumor-net-cancer-community 2022-07-07T10:25:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/sandoz-inc-and-its-affiliate-novartis-pharmaceuticals-corporation-voluntarily-recall-select-blister-packages-products-us-due-packaging-requirements-child-resistance 2022-07-07T10:25:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-highlight-findings-from-large-global-patient-survey-revealing-worldwide-approximately-60-employed-people-migraine-missed-average-week-work-month 2022-07-07T10:25:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-funding-patient-advocacy-initiatives-support-and-empower-metastatic-breast-cancer-community 2022-07-25T11:29:18-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-inclusion-new-evidence-cosentyx-inhibits-progression-joint-structural-damage-psoriatic-arthritis 2022-07-07T10:25:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-juliet-trial-kymriah-demonstrates-more-one-year-durability-responses-adults-relapsed-or-refractory-dlbcl 2022-07-07T10:25:14-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-survey-uncovers-real-world-impact-immune-thrombocytopenia-or-itp-rare-blood-disease-patients-quality-life 2022-07-07T10:25:14-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-hrher2-advanced-breast-cancer 2022-07-07T10:25:14-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa 2022-07-07T10:25:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patient-reported-outcomes-tool-revealed-significant-improvement-symptom-frequency-and-quality-life-domains-entresto 2022-07-07T10:25:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-aooe-novel-treatment-developed-specifically-migraine-prevention 2022-07-07T10:25:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-reinforce-companys-commitment-reimagining-cancer 2022-07-07T10:25:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-teams-venus-williams-tennis-champion-and-dry-eye-sufferer-launch-systane-complete-eye-drops 2022-07-07T10:25:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-gilenya-first-disease-modifying-therapy-pediatric-relapsing-multiple-sclerosis 2022-07-07T10:25:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kymriah-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma 2022-07-07T10:25:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-air-optix-colors-contact-lenses-gemstone-collection-creating-new-ways-enhance-and-play-eye-color 2022-07-20T16:07:02-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-phase-iii-data-brolucizumab-demonstrate-reliability-12-week-treatment-interval 2022-07-07T10:25:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-focalview-app-providing-opportunity-patients-participate-ophthalmology-clinical-trials-from-home 2022-07-07T10:25:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/phase-iii-data-lancet-show-novartis-siponimod-significantly-improved-outcomes-patients-secondary-progressive-ms 2022-07-07T10:25:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-show-cosentyx-improved-quality-life-over-5-years-two-thirds-patients-moderate-severe-plaque-psoriasis 2022-07-07T10:25:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis 2022-07-07T10:25:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-reinforces-superiority-cosentyx-versus-stelara-achieving-skin-clearance-psoriasis-patients 2022-07-07T10:25:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-receives-fda-breakthrough-therapy-designation-first-line-use-severe-aplastic-anemia-saa 2022-07-07T10:25:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-received-fda-breakthrough-therapy-designation-initial-endocrine-based-treatment-premenopausal-women-hrher2-advanced-breast-cancer 2022-07-07T10:25:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-multiple-sclerosis-therapy-fingolimod-granted-fda-breakthrough-therapy-designation-pediatric-ms 2022-07-07T10:25:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-crizanlizumab-shown-prolong-time-patients-first-sickle-cell-pain-crisis-subgroup-analysis-sustain-study 2022-07-07T10:25:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/primary-analysis-results-from-novartis-pivotal-juliet-trial-show-kymriahtm-tisagenlecleucel-sustained-complete-responses-six-months-adults-rr-dlbcl-difficult-treat-cancer 2022-07-07T10:25:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-initiates-study-evaluating-impact-higher-dosing-cosentyx-patients-ankylosing-spondylitis 2022-07-07T10:25:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-first-and-only-cdk46-inhibitor-show-superior-median-pfs-compared-oral-endocrine-therapy-first-line-treatment-prospective-randomized-phase-iii-trial-dedicated-premenopausal-women-hrher2-advanced-breast-cancer 2022-07-07T10:25:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-sabcs-across-broad-range-breast-cancer-patient-populations-combination-treatments-and-lines-therapy 2022-07-07T10:25:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-canakinumab-acz885-reduced-cardiovascular-risk-25-subgroup-cantos-phase-iii-trial-participants 2022-07-07T10:25:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-brolucizumab-rth258-demonstrates-superiority-versus-aflibercept-key-secondary-endpoint-measures-disease-activity-namd-leading-cause-blindness 2022-07-07T10:25:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-study-data-demonstrating-cosentyx-reduced-signs-and-symptoms-psoriatic-arthritis-while-inhibiting-progression-joint-structural-damage 2022-07-07T10:25:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-ash-patients-serious-blood-disorders-lymphoma-leukemia-and-sickle-cell-disease 2022-07-07T10:25:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-data-show-children-and-adolescents-relapsing-ms-had-82-lower-relapse-rate-fingolimod-vs-interferon-beta-1a 2022-07-07T10:25:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-collaborates-pop-icon-cyndi-lauper-release-new-song-honor-world-psoriasis-day 2022-07-07T10:25:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp 2022-07-07T10:25:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-dailies-teams-us-olympians-world-class-gymnast-laurie-hernandez-and-soccer-star-tobin-heath-launch-invisible-edge-campaign 2022-07-07T10:25:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-actress-producer-and-activist-eva-longoria-launch-kiss-4-mbctm-generate-research-funding-and-support-metastatic-breast-cancer-community 2022-07-07T10:25:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-efficacy-and-safety-phase-iii-data 2022-07-07T10:25:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-now-available-novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice 2022-07-07T10:25:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice 2022-07-07T10:25:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-first-large-scale-research-study-multiple-sclerosis-allows-participants-contribute-from-smartphones 2022-07-07T10:25:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-biologics-license-application-amg-334-erenumab-important-regulatory-milestone-novartis 2022-07-07T10:25:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-confirms-5-year-data-first-and-only-fully-human-il-17a-inhibitor-cosentyx-reinforcing-sustained-efficacy-and-safety-profile-psoriasis 2022-07-07T10:25:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-ctl019-6-month-follow-data-show-durable-remission-rates-children-young-adults-rr-b-cell-all 2022-07-07T10:25:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl 2022-07-07T10:25:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-first-its-kind-kisqali-femara-co-pack-initial-treatment-hrher2-advanced-or-metastatic-breast-cancer 2022-07-07T10:25:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-global-collaboration-amgen-commercialize-first-class-amg-334-erenumab-program-migraine-prevention-us-and-canada 2022-07-07T10:25:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-car-t-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-treatment-adult-patients-rr-dlbcl 2022-07-07T10:25:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-first-car-t-cell-therapy-bla-pediatric-and-young-adult-patients-rr-b-cell-all-granted-fda-priority-review 2022-07-07T10:25:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes 2022-07-07T10:25:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following-treatment-pause 2022-07-07T10:25:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-receives-us-fda-approval-acrysof-iq-restor-30d-multifocal-toric-intraocular-lens-cataract-patients 2022-07-07T10:26:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-out-licenses-three-copd-products-us 2022-07-07T10:26:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all 2022-07-07T10:26:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths 2022-07-07T10:26:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-new-air-optix-plus-hydraglyde-monthly-replacement-contact-lenses-american-academy-optometry-annual-meeting 2022-07-07T10:26:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-partners-prominent-us-health-advocacy-organizations-launch-first-social-networking-platform-heart-failure-patients-and-their-loved-ones 2022-07-07T10:26:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-show-cosentyx-continues-deliver-high-skin-clearance-majority-psoriasis-patients-four-years 2022-07-07T10:26:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions 2022-07-07T10:26:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-new-analysis-shows-novartis-entresto-associated-higher-relative-health-related-quality-life-scores-among-hfref-patients 2022-07-07T10:26:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-baf312-reduced-risk-disability-progression-pivotal-phase-iii-study-secondary-progressive-ms-patients 2022-07-07T10:26:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-finds-relapsing-ms-patients-gilenya-had-greater-treatment-retention-and-satisfaction-rates-vs-injectable-dmts 2022-07-07T10:26:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma 2022-07-07T10:26:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/largest-global-psoriasis-survey-shows-85-us-respondents-faced-social-stigma-discrimination-and-humiliation-because-their-skin 2022-07-07T10:26:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/timely-use-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-year-among-hfref-patients-according-expert-analysis-jama-cardiology 2022-07-07T10:26:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-gilenya-had-significantly-greater-patient-retention-compared-idmts-relapsing-remitting-ms 2022-07-07T10:26:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-leading-us-cardiology-societies-strongly-recommend-entresto-new-standard-care-treatment-earlier-expected-joint-update-clinical-practice-guidelines-heart-failure 2022-07-07T10:26:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-fortihfy-global-clinical-program-entresto 2022-07-07T10:26:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-fda-breakthrough-therapy-designations-ilaris-treat-rare-types-periodic-fever-syndromes 2022-07-07T10:26:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analyses-show-novartis-entrestotm-reduced-cardiovascular-death-or-hospitalization-heart-failure-consistently-benefitting-patients-reduced-ejection-fraction-hfref-regardless-prior-heart-failure-hospital-admissions-or-background 2022-07-07T10:26:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52 2022-07-07T10:26:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-indication-novartis-drug-afinitor-progressive-nonfunctional-gi-and-lung-neuroendocrine-tumors-net 2022-07-07T10:26:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-two-new-fda-approvals-cosentyx-secukinumab-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis 2022-07-07T10:26:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-publication-two-landmark-studies-nejm-demonstrating-efficacy-cosentyx-patients-ankylosing-spondylitis 2022-07-07T10:26:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-phase-ii-data-demonstrating-93-complete-remission-pediatric-patients-rr-all 2022-07-07T10:26:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-ctl019-study-data-demonstrating-overall-response-adult-patients-certain-types-lymphoma 2022-07-07T10:26:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-finalizes-settlement-agreement-resolving-civil-suit-filed-us-attorneys-office-southern-district-new-york 2022-07-07T10:26:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-entrestotm-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows 2022-07-07T10:26:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/80-ankylosing-spondylitis-patients-treated-cosentyx-show-no-spinal-x-ray-progression-shown-novartis-new-two-year-observational-data 2022-07-07T10:26:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data 2022-07-07T10:26:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-novartis-dual-combination-bronchodilator-utibrontm-neohaler-patients-chronic-obstructive-pulmonary-disease 2022-07-07T10:26:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-clarification-specialty-pharmacy-settlement-principle-announcement 2022-07-07T10:26:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-secukinumab-phase-iii-data-confirming-significant-efficacy-patients-psoriatic-arthritis 2022-07-07T10:26:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patients-aggressive-form-melanoma-lived-more-two-years-average-when-taking-novartis-therapies-tafinlar-mekinist 2022-07-07T10:26:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-novartis-access-portfolio-affordable-medicines-treat-chronic-diseases-lower-income-countries 2022-07-07T10:26:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-odomzo-sonidegib-locally-advanced-basal-cell-carcinoma-labcc-form-skin-cancer 2022-07-07T10:26:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-approved-fda-reduce-risk-cardiovascular-death-and-heart-failure-hospitalization-now-called-entrestotm-sacubitrilvalsartan 2022-07-07T10:26:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-wcd-shows-significant-efficacy-cosentyx-patients-psoriasis-palms-soles-feet-and-nails 2022-07-07T10:26:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-ctl019-data-showing-its-potential-treatment-specific-types-hard-treat-non-hodgkin-lymphoma 2022-07-07T10:26:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma 2022-07-07T10:26:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-dual-bronchodilator-significantly-improved-lung-function-compared-single-bronchodilators-patients-moderate-severe-copd-phase-iii-studies 2022-07-07T10:26:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload 2022-07-07T10:26:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-cosentyxtm-two-year-efficacy-and-safety-data-showing-sustainable-effect-psoriasis-patients 2022-07-07T10:26:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-more-cosentyxtm-treated-psoriasis-patients-achieved-clear-or-almost-clear-skin-pasi-90-compared-stelara 2022-07-07T10:26:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review 2022-07-25T11:40:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-first-il-17a-antagonist-cosentyxtm-secukinumab-moderate-severe-plaque-psoriasis-patients 2022-07-07T10:26:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder 2022-07-07T10:26:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia 2022-07-07T10:26:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nine-new-analyses-show-novartis-lcz696-could-change-course-heart-failure-patients 2022-07-07T10:26:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-first-il-17a-phase-iii-results-show-ain457-secukinumab-significantly-improves-psoriatic-arthritis-patients 2022-07-07T10:26:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ain457-secukinumab-showed-significant-symptom-improvement-two-pivotal-phase-iii-ankylosing-spondylitis-studies 2022-07-07T10:26:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-present-first-il-17a-phase-iii-data-ain457-secukinumab-psoriatic-arthritis-and-ankylosing-spondylitis-acr-2014 2022-07-07T10:26:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-multiple-sclerosis-advocate-and-musician-david-osmond-launch-ms-education-initiative-our-voice-songtm 2022-07-07T10:26:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-advisory-committee-unanimously-recommends-approval-ain457-secukinumab-patients-moderate-severe-plaque-psoriasis 2022-07-07T10:26:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-ctl019-data-published-nejm-demonstrating-efficacy-certain-patients-acute-lymphoblastic-leukemia-all 2022-07-07T10:26:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-first-treatment-advanced-pancreatic-net-provide-overall-survival-more-35-years-phase-iii-trial 2022-07-07T10:26:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-cut-cardiovascular-deaths-20-vs-ace-inhibitor-landmark-paradigm-hf-trial 2022-07-07T10:26:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-showcase-heart-failure-leadership-esc-congress-2014-results-new-first-its-type-medicine-lcz696 2022-07-07T10:26:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-two-pivotal-phase-iii-secukinumab-studies-demonstrating-statistically-significant-skin-clearance-psoriasis-patients 2022-07-07T10:26:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-personalized-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation 2022-07-07T10:27:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/pivotal-data-novartis-investigational-compound-lde225-show-marked-tumor-responses-advanced-basal-cell-carcinoma 2022-07-07T10:27:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-key-advances-cancer-research-asco-and-eha-from-four-new-pivotal-studies-lung-blood-and-skin-cancers 2022-07-07T10:27:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-lar-shows-superior-efficacy-acromegaly-patients-not-controlled-first-generation-somatostatin-analogues 2022-07-07T10:27:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-new-phase-iii-data-showing-secukinumab-ain457-improved-moderate-severe-plaque-psoriasis-patients 2022-07-07T10:27:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives 2022-07-07T10:27:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-stands-behind-medication-adherence-activities-and-reaffirms-commitment-patient-safety 2022-07-07T10:27:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia 2022-07-07T10:27:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-hosts-competition-create-novel-mobile-solutions-heart-failure-caregivers 2022-07-07T10:27:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-data-effects-investigational-rlx030-kidney-blood-flow-chronic-heart-failure-patients 2022-07-07T10:27:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-exelon-patch-now-fda-approved-treat-patients-across-all-stages-alzheimers-disease 2022-07-07T10:27:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-novartis-team-inspire-people-ms-through-innovative-tandem-cycling-campaign 2022-07-07T10:27:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/relapsing-ms-patients-more-satisfied-novartis-oral-drug-gilenya-standard-injectable-therapies-according-new-study-results-cmsc 2022-07-07T10:27:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-findings-advancing-care-patients-170-abstracts-breast-lung-and-blood-cancers-asco-and-eha 2022-07-07T10:27:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-disputes-allegations-two-us-government-lawsuits-and-looks-forward-fair-discussion-facts 2022-07-07T10:27:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-tobi-podhalertm-certain-cystic-fibrosis-patients-first-and-only-dry-powder-inhaled-antibacterial-us 2022-07-07T10:27:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-drug-gilenya-significantly-reduced-rate-brain-volume-loss-across-three-large-phase-iii-studies 2022-07-07T10:27:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-omalizumab-significantly-improved-chronic-idiopathic-urticaria-symptoms-patients-who-failed-standard-therapy 2022-07-07T10:27:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-zortress-first-over-decade-approved-fda-prevent-organ-rejection-adult-liver-transplant-patients 2022-07-07T10:27:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-exjade-first-treatment-approved-fda-chronic-iron-overload-patients-non-transfusion-dependent-thalassemia 2022-07-07T10:27:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nejm-published-study-shows-novartis-compound-acz885-significantly-relieves-symptoms-patients-serious-form-childhood-arthritis 2022-07-07T10:27:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder 2022-07-07T10:27:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder 2022-07-07T10:27:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure 2022-07-07T10:27:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/leeza-gibbons-joins-novartis-improve-caregiving-experience-millions-americans-through-real-world-peer-advice-alzheimersdiseasecom 2022-07-07T10:27:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-emprende-una-campana-de-educacion-de-la-comunidad-hispana-de-ee-uu-sobre-la-enfermedad-de-alzheimer 2022-07-07T10:27:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-embarks-alzheimers-disease-educational-effort-us-hispanic-community 2022-07-07T10:27:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis 2022-07-07T10:27:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-approved-fda-patients-mild-moderate-alzheimers-disease 2022-07-07T10:27:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/npc-statement-comments-made-media-coverage-paycheck-fairness-act 2022-07-07T10:27:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients 2022-07-07T10:27:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-professional-women-cyclists-join-novartis-raise-awareness-multiple-sclerosis 2022-07-07T10:27:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-showed-statistically-significantly-less-decline-function-alzheimers-vs-lower-dose 2022-07-07T10:27:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-extension-study-data-novartis-drug-gilenya-shows-patients-successfully-treated-7-years-relapsing-ms 2022-07-07T10:27:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-update-united-states-prescribing-information-ms-therapy-gilenya-following-fda-review 2022-07-07T10:27:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-transplant-portfolio-hecoria-first-generic-tacrolimus-can-be-prescribed-brand-name 2022-07-07T10:27:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease 2022-07-07T10:27:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/plaintiff-sales-representatives-and-novartis-pharmaceuticals-corporation-resolve-class-action-wage-and-hour-claims 2022-07-07T10:27:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-study-exjade-shows-significant-reduction-iron-overload-patients-non-transfusion-dependent-thalassemia 2022-07-07T10:27:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-novartis-phase-iii-studies-show-twice-many-ph-cml-patients-achieve-deeper-levels-response-tasigna-compared-gleevec 2022-07-07T10:27:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-acz885-helped-substantially-reduce-steroid-use-45-patients-serious-form-childhood-arthritis 2022-07-07T10:27:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-helps-women-advanced-breast-cancer-live-significantly-longer-without-their-disease-progressing 2022-07-07T10:27:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-shows-qti571-significantly-improved-walking-distance-patients-life-threatening-pulmonary-arterial-hypertension 2022-07-07T10:27:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-effective-patients-non-cancerous-kidney-tumors-associated-tsc-phase-iii-trial 2022-07-07T10:27:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-showed-acz885-provided-substantial-symptom-relief-84-patients-most-serious-form-childhood-arthritis 2022-07-07T10:27:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-supplemental-new-drug-application-novartis-therapy-gilenyatm-include-data-showing-reduction-t1-lesions-ms-marker-disease-activity 2022-07-07T10:27:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease 2022-07-07T10:27:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-shows-acz885-severe-gouty-arthritis-provided-better-pain-relief-and-reduced-risk-new-attacks-68-vs-steroid 2022-07-07T10:27:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-phil-keoghan-host-amazing-race-raise-awareness-multiple-sclerosis-through-inspirational-national-bike-tour 2022-07-07T10:27:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-afinitor-first-new-treatment-nearly-three-decades-patients-advanced-pancreatic-net 2022-07-07T10:27:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-therapy-gilenyatm-reduced-risk-ms-disability-progression-regardless-treatment-history-or-disease-severity-new-analysis-shows 2022-07-07T10:27:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-recommends-us-approval-novartis-once-daily-bronchodilator-qab149-copd 2022-07-07T10:27:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-information-extavia-interferon-beta-1-b-patients-regarding-triad-groups-alcohol-prep-products 2022-07-07T10:27:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-amturnidetm-triple-combination-pill-treat-high-blood-pressure-patients-uncontrolled-two-medications 2022-07-07T10:27:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-surpass-gleevec-slowing-disease-progression-patients-newly-diagnosed-cml 2022-07-07T10:27:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-restructuring-us-field-force-align-changing-product-portfolio-and-strategic-growth-priorities 2022-07-07T10:27:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-stand-together-ad-campaign-provides-strength-support-and-important-resources-11-million-alzheimers-caregivers 2022-07-07T10:28:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/analysis-shows-novartis-drug-tobi-associated-reduced-mortality-cystic-fibrosis-patients-common-lung-infection 2022-07-07T10:28:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-gilenyatm-novel-first-line-multiple-sclerosis-treatment-shown-significantly-reduce-relapses-and-delay-disability-progression 2022-07-07T10:28:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-tekamlotm-single-pill-combination-aliskiren-and-amlodipine-treat-high-blood-pressure 2022-07-07T10:28:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-affiliate-novartis-strongly-disputes-claims-past-discrimination-us 2022-07-07T10:28:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-prevails-medicaid-pricing-case-alabama-supreme-court 2022-07-07T10:28:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-tekturna-hct-initial-treatment-patients-unlikely-achieve-their-blood-pressure-goals-single-agent 2022-07-07T10:28:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-new-biological-therapy-ilaris-approved-us-treat-children-and-adults-caps-serious-life-long-auto-inflammatory-disease 2022-07-07T10:28:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-fda-approves-exforge-hct-only-high-blood-pressure-treatment-combine-three-medications-single-pill 2022-07-07T10:28:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-gleevec-receives-us-approval-first-treatment-reduce-risk-cancer-returning-patients-gastrointestinal-stromal-tumors 2022-07-07T10:28:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial 2022-07-07T10:28:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-novartis-vaccines-and-pta-battle-flu-public-health-vaccination-initiative-urges-families-lets-fight-flu-together 2022-07-07T10:28:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-show-potential-imatinib-mesylate-tablets-treat-life-threatening-form-pulmonary-artery-disease 2022-07-07T10:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-combined-sandostatin-lar-depot-and-monotherapy-controls-growth-rare-pancreatic-neuroendocrine-tumors 2022-07-07T10:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-granted-priority-review-us-based-potential-fill-unmet-medical-need-patients-advanced-kidney-cancer 2022-07-07T10:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-appeal-judgment-alabama-pricing-case 2022-07-07T10:28:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-higher-initial-dose-gleevec-achieved-better-early-responses-standard-dose-patients-chronic-myeloid-leukemia 2022-07-07T10:28:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-presented-asco-show-potential-rad001-enhance-efficacy-and-overcome-resistance-breast-cancer-treatments 2022-07-20T16:05:08-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-major-independent-trial-demonstrates-significant-anticancer-benefit-zometa-women-early-stage-breast-cancer 2022-07-07T10:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-more-doubles-time-without-tumor-growth-after-failure-standard-treatment-patients-advanced-kidney-cancer 2022-07-07T10:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/strength-and-innovation-novartis-oncology-products-and-pipeline-potential-improve-patient-treatment-demonstrated-more-170-abstracts-asco-annual-meeting 2022-07-07T10:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-femara-helps-protect-against-return-breast-cancer-even-when-treatment-starts-several-years-after-completing-tamoxifen-therapy 2022-07-07T10:28:23-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy 2022-07-07T10:28:23-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-and-photo-tekturna-hct-single-tablet-combination-tekturna-and-diuretic-receives-us-approval-treatment-high-blood-pressure 2022-07-07T10:28:23-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/photo-new-data-show-gleevec-halts-progression-advanced-stages-life-threatening-form-leukemia-sixth-year-treatment 2022-07-07T10:28:26-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2005-release 2022-07-07T10:28:26-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2004-release 2022-07-07T10:28:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-acquires-kedalion-therapeutics-and-its-innovative-ocular-delivery-platform-could-transform-patient-experience 2022-07-20T15:51:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-four-year-data-efficacy-and-safety-kesimpta-ofatumumab 2022-10-11T20:23:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-tafinlar-mekinist-approved-fda-pediatric-patients-braf-v600e-low-grade-glioma-most-common-pediatric-brain-cancer 2023-03-17T12:24:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ribociclib-kisqali-only-category-1-preferred-first-line-treatment-option-hrher2-mbc-combination-ai-updated-nccn-clinical-practice-guidelines-oncology-nccn-guidelines 2023-03-29T10:40:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-vijoice-alpelisib-first-and-only-treatment-select-patients-pik3ca-related-overgrowth-spectrum-pros-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-enthesitis-related-arthritis-and-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-leqvio-inclisiran-first-class-sirna-lower-cholesterol-and-keep-it-low-two-doses-year-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-t-chargetm-next-generation-car-t-platform-first-human-data-ash-2021-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-strong-responses-high-risk-patients-relapsed-or-refractory-follicular-lymphoma-extended-study-follow-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-highlight-efficacy-piqray-hrher2-metastatic-breast-cancer-pik3ca-driver-mutation-immediately-post-cdk46i-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-kisqali-data-shows-consistent-overall-survival-benefit-across-genomic-and-clinical-subtypes-interest-hrher2-metastatic-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-iptacopan-meets-primary-endpoints-phase-ii-study-rare-kidney-disease-c3-glomerulopathy-c3g-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-scemblix-asciminib-novel-mechanism-action-treatment-chronic-myeloid-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-kisqali-data-showing-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-findings-from-real-world-study-alpelisib-demonstrating-clinical-benefit-people-pik3ca-related-overgrowth-spectrum-pros-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-meet-pros-raise-awareness-and-support-education-pik3ca-related-overgrowth-spectrum-pros-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges-universities-medical-schools-and-other-leading-organizations-co-create-effective-measurable-solutions-health-equity-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-checkpoint-inhibitor-tislelizumab-met-primary-endpoint-overall-survival-pivotal-phase-iii-trial-esophageal-cancer-after-systemic-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study-1 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates-and-remarkable-safety-profile-relapsed-or-refractory-follicular-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reports-longest-median-overall-survival-postmenopausal-hrher2-metastatic-breast-cancer-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-commits-addressing-racial-disparities-breast-cancer-screening-treatment-and-care-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-beovu-data-show-potential-fluid-resolution-more-diabetic-macular-edema-patients-fewer-injections-versus-aflibercept-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-xolair-omalizumab-self-injection-prefilled-syringe-across-all-indications-appropriate-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-fda-advisory-committee-recommendation-use-entresto-treat-patients-hfpef-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-bosulif-chronic-myeloid-leukemia-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-partner-karamo-brown-support-and-empower-people-living-migraine-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-adults-nasal-polyps-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-data-ash-reinforce-breadth-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-analyses-investigational-inclisiran-demonstrate-consistently-effective-and-sustained-ldl-c-reduction-month-17-regardless-age-and-gender-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-early-synovitis-reduction-patients-psoriatic-arthritis-first-its-kind-study-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-five-year-data-reinforce-safety-and-efficacy-profile-aimovig-erenumab-aooe-adult-patients-episodic-migraine-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-commits-25m-improve-health-equity-reducing-health-disparities-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-shows-high-consistency-lowering-ldl-c-individual-response-investigational-inclisiran-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-know-podcast-series-hosted-music-icon-cyndi-lauper-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-prefilled-syringe-self-administration-across-all-indications-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-phase-iii-asclepios-trials-demonstrating-superior-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-treated-tafinlar-mekinist-following-surgery-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-underscoring-commitment-advancing-treatment-relapsing-forms-multiple-sclerosis-rms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-overall-survival-benefit-hrher2-advanced-breast-cancer-consistent-findings-patients-more-aggressive-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-met-inhibitor-tabrectatm-metastatic-non-small-cell-lung-cancer-metex14-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-supports-telehealth-programs-provide-access-care-new-jerseys-most-vulnerable-communities-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-met-inhibitor-capmatinib-inc280-first-potential-treatment-metex14-mutated-advanced-non-small-cell-lung-cancer-granted-priority-fda-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/public-private-collaboration-commits-accelerate-access-health-services-africa-reaching-17-million-people-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-us-patients-when-used-real-world-setting-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-medicine-adakveo-crizanlizumab-tmca-approved-fda-reduce-frequency-pain-crises-individuals-living-sickle-cell-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-work-music-icon-cyndi-lauper-bring-life-impact-psoriasis-can-have-workplace-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-now-accepting-submissions-proposals-address-unmet-patient-needs-cancer-biomarker-testing-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presents-new-data-epns-continuing-show-significant-therapeutic-benefit-zolgensma-prolonging-event-free-survival-now-5-years-age-patients-spinal-muscular-atrophy-sma-type-1-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/entresto-improved-measures-heart-structure-and-function-hfref-patients-new-novartis-study-additional-data-complement-findings-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-celebrity-interior-designer-nate-berkus-launch-my-home-sight-program-empowering-people-wet-amd-live-more-independently-home-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-file-and-accelerates-review-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-offers-free-genetic-mutation-testing-program-advanced-melanoma-patients-results-can-help-doctors-and-patients-making-cancer-treatment-decisions-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/long-term-survival-benefit-shown-metastatic-melanoma-patients-treated-novartis-tafinlar-mekinist-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-shows-growing-strength-lung-cancer-innovation-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-demonstrate-novel-approaches-reimagining-medicine-cancer-and-serious-blood-disorders-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/five-nonprofit-organizations-receive-250000-through-novartis-step-programtm-support-sickle-cell-patient-initiatives-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-promacta-125-mg-oral-suspension-due-potential-peanut-contamination-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-avexis-data-aan-showed-long-term-durability-zolgensma-patients-spinal-muscular-atrophy-sma-type-1-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presented-robust-data-aan-demonstrating-efficacy-zolgensma-broad-spectrum-spinal-muscular-atrophy-sma-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-purchase-advanced-biologics-therapy-manufacturing-campus-longmont-colorado-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-further-support-initiation-entresto-hospital-and-first-choice-systolic-heart-failure-therapy-stabilized-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-psoriasis-patients-treated-cosentyx-reported-improvements-quality-life-measures-early-week-4-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation-prevention-vaso-occlusive-crises-sickle-cell-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-demonstrates-consistent-efficacy-and-tolerability-kisqali-combination-therapy-hrher2-advanced-breast-cancer-patients-difficult-treat-visceral-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-consistently-improved-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-new-solar-1-analyses-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-longer-term-analyses-from-pivotal-kymriah-trials-showed-durable-responses-are-maintained-patients-advanced-blood-cancers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-crizanlizumab-seg101-data-analysis-sickle-cell-disease-and-investment-sentry-clinical-program-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-fund-five-innovative-ideas-support-patients-and-sickle-cell-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-study-supports-entresto-foundational-hfref-therapy-and-hospital-initiation-appropriate-stabilized-heart-failure-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-ash-and-sabcs-show-strength-pipeline-and-portfolio-hematology-and-oncology-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-wins-esteemed-prix-galien-foundation-best-biotechnology-product-award-car-t-cell-therapy-kymriah-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-year-data-novartis-brolucizumab-reaffirm-superiority-versus-aflibercept-reducing-retinal-fluid-patients-namd-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-cosentyx-data-demonstrating-long-term-response-and-safety-ankylosing-spondylitis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-analysis-shows-crizanlizumab-seg101-increased-number-patients-free-sickle-cell-pain-crises-vs-placebo-during-sustain-study-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-siponimod-baf312-first-and-only-oral-drug-shown-delay-disability-progression-typical-spms-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-recording-artist-and-actress-jordin-sparks-and-scdaa-launch-generation-s-inspiring-new-sickle-cell-storytelling-project-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-landmark-paradigms-study-demonstrating-significant-benefit-gilenya-children-and-adolescents-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-now-first-and-only-cdk46-inhibitor-indicated-us-first-line-therapy-specifically-premenopausal-women-and-initial-therapy-fulvestrant-postmenopausal-women-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-galaxies-hope-app-digital-experience-neuroendocrine-tumor-net-cancer-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/sandoz-inc-and-its-affiliate-novartis-pharmaceuticals-corporation-voluntarily-recall-select-blister-packages-products-us-due-packaging-requirements-child-resistance-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-highlight-findings-from-large-global-patient-survey-revealing-worldwide-approximately-60-employed-people-migraine-missed-average-week-work-month-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-funding-patient-advocacy-initiatives-support-and-empower-metastatic-breast-cancer-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-inclusion-new-evidence-cosentyx-inhibits-progression-joint-structural-damage-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-juliet-trial-kymriah-demonstrates-more-one-year-durability-responses-adults-relapsed-or-refractory-dlbcl-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-survey-uncovers-real-world-impact-immune-thrombocytopenia-or-itp-rare-blood-disease-patients-quality-life-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patient-reported-outcomes-tool-revealed-significant-improvement-symptom-frequency-and-quality-life-domains-entresto-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-aooe-novel-treatment-developed-specifically-migraine-prevention-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-reinforce-companys-commitment-reimagining-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-teams-venus-williams-tennis-champion-and-dry-eye-sufferer-launch-systane-complete-eye-drops-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-gilenya-first-disease-modifying-therapy-pediatric-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kymriah-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-air-optix-colors-contact-lenses-gemstone-collection-creating-new-ways-enhance-and-play-eye-color-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-phase-iii-data-brolucizumab-demonstrate-reliability-12-week-treatment-interval-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-focalview-app-providing-opportunity-patients-participate-ophthalmology-clinical-trials-from-home-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/phase-iii-data-lancet-show-novartis-siponimod-significantly-improved-outcomes-patients-secondary-progressive-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-show-cosentyx-improved-quality-life-over-5-years-two-thirds-patients-moderate-severe-plaque-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-reinforces-superiority-cosentyx-versus-stelara-achieving-skin-clearance-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-receives-fda-breakthrough-therapy-designation-first-line-use-severe-aplastic-anemia-saa-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-received-fda-breakthrough-therapy-designation-initial-endocrine-based-treatment-premenopausal-women-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-multiple-sclerosis-therapy-fingolimod-granted-fda-breakthrough-therapy-designation-pediatric-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-crizanlizumab-shown-prolong-time-patients-first-sickle-cell-pain-crisis-subgroup-analysis-sustain-study-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/primary-analysis-results-from-novartis-pivotal-juliet-trial-show-kymriahtm-tisagenlecleucel-sustained-complete-responses-six-months-adults-rr-dlbcl-difficult-treat-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-initiates-study-evaluating-impact-higher-dosing-cosentyx-patients-ankylosing-spondylitis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-first-and-only-cdk46-inhibitor-show-superior-median-pfs-compared-oral-endocrine-therapy-first-line-treatment-prospective-randomized-phase-iii-trial-dedicated-premenopausal-women-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-sabcs-across-broad-range-breast-cancer-patient-populations-combination-treatments-and-lines-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-canakinumab-acz885-reduced-cardiovascular-risk-25-subgroup-cantos-phase-iii-trial-participants-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-brolucizumab-rth258-demonstrates-superiority-versus-aflibercept-key-secondary-endpoint-measures-disease-activity-namd-leading-cause-blindness-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-study-data-demonstrating-cosentyx-reduced-signs-and-symptoms-psoriatic-arthritis-while-inhibiting-progression-joint-structural-damage-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-ash-patients-serious-blood-disorders-lymphoma-leukemia-and-sickle-cell-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-data-show-children-and-adolescents-relapsing-ms-had-82-lower-relapse-rate-fingolimod-vs-interferon-beta-1a-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-collaborates-pop-icon-cyndi-lauper-release-new-song-honor-world-psoriasis-day-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-dailies-teams-us-olympians-world-class-gymnast-laurie-hernandez-and-soccer-star-tobin-heath-launch-invisible-edge-campaign-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-actress-producer-and-activist-eva-longoria-launch-kiss-4-mbctm-generate-research-funding-and-support-metastatic-breast-cancer-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-efficacy-and-safety-phase-iii-data-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-now-available-novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-first-large-scale-research-study-multiple-sclerosis-allows-participants-contribute-from-smartphones-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-biologics-license-application-amg-334-erenumab-important-regulatory-milestone-novartis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-confirms-5-year-data-first-and-only-fully-human-il-17a-inhibitor-cosentyx-reinforcing-sustained-efficacy-and-safety-profile-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-ctl019-6-month-follow-data-show-durable-remission-rates-children-young-adults-rr-b-cell-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-first-its-kind-kisqali-femara-co-pack-initial-treatment-hrher2-advanced-or-metastatic-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-global-collaboration-amgen-commercialize-first-class-amg-334-erenumab-program-migraine-prevention-us-and-canada-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-car-t-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-treatment-adult-patients-rr-dlbcl-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-first-car-t-cell-therapy-bla-pediatric-and-young-adult-patients-rr-b-cell-all-granted-fda-priority-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following-treatment-pause-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-receives-us-fda-approval-acrysof-iq-restor-30d-multifocal-toric-intraocular-lens-cataract-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-out-licenses-three-copd-products-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-new-air-optix-plus-hydraglyde-monthly-replacement-contact-lenses-american-academy-optometry-annual-meeting-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-partners-prominent-us-health-advocacy-organizations-launch-first-social-networking-platform-heart-failure-patients-and-their-loved-ones-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-show-cosentyx-continues-deliver-high-skin-clearance-majority-psoriasis-patients-four-years-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-new-analysis-shows-novartis-entresto-associated-higher-relative-health-related-quality-life-scores-among-hfref-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-baf312-reduced-risk-disability-progression-pivotal-phase-iii-study-secondary-progressive-ms-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-finds-relapsing-ms-patients-gilenya-had-greater-treatment-retention-and-satisfaction-rates-vs-injectable-dmts-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/largest-global-psoriasis-survey-shows-85-us-respondents-faced-social-stigma-discrimination-and-humiliation-because-their-skin-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/timely-use-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-year-among-hfref-patients-according-expert-analysis-jama-cardiology-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-gilenya-had-significantly-greater-patient-retention-compared-idmts-relapsing-remitting-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-leading-us-cardiology-societies-strongly-recommend-entresto-new-standard-care-treatment-earlier-expected-joint-update-clinical-practice-guidelines-heart-failure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-fortihfy-global-clinical-program-entresto-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-fda-breakthrough-therapy-designations-ilaris-treat-rare-types-periodic-fever-syndromes-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analyses-show-novartis-entrestotm-reduced-cardiovascular-death-or-hospitalization-heart-failure-consistently-benefitting-patients-reduced-ejection-fraction-hfref-regardless-prior-heart-failure-hospital-admissions-or-background-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-indication-novartis-drug-afinitor-progressive-nonfunctional-gi-and-lung-neuroendocrine-tumors-net-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-two-new-fda-approvals-cosentyx-secukinumab-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-publication-two-landmark-studies-nejm-demonstrating-efficacy-cosentyx-patients-ankylosing-spondylitis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-phase-ii-data-demonstrating-93-complete-remission-pediatric-patients-rr-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-ctl019-study-data-demonstrating-overall-response-adult-patients-certain-types-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-finalizes-settlement-agreement-resolving-civil-suit-filed-us-attorneys-office-southern-district-new-york-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-entrestotm-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/80-ankylosing-spondylitis-patients-treated-cosentyx-show-no-spinal-x-ray-progression-shown-novartis-new-two-year-observational-data-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-novartis-dual-combination-bronchodilator-utibrontm-neohaler-patients-chronic-obstructive-pulmonary-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-clarification-specialty-pharmacy-settlement-principle-announcement-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-secukinumab-phase-iii-data-confirming-significant-efficacy-patients-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patients-aggressive-form-melanoma-lived-more-two-years-average-when-taking-novartis-therapies-tafinlar-mekinist-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-novartis-access-portfolio-affordable-medicines-treat-chronic-diseases-lower-income-countries-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-odomzo-sonidegib-locally-advanced-basal-cell-carcinoma-labcc-form-skin-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-approved-fda-reduce-risk-cardiovascular-death-and-heart-failure-hospitalization-now-called-entrestotm-sacubitrilvalsartan-0 2025-02-13T11:41:27-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-wcd-shows-significant-efficacy-cosentyx-patients-psoriasis-palms-soles-feet-and-nails-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-ctl019-data-showing-its-potential-treatment-specific-types-hard-treat-non-hodgkin-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-dual-bronchodilator-significantly-improved-lung-function-compared-single-bronchodilators-patients-moderate-severe-copd-phase-iii-studies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-cosentyxtm-two-year-efficacy-and-safety-data-showing-sustainable-effect-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-more-cosentyxtm-treated-psoriasis-patients-achieved-clear-or-almost-clear-skin-pasi-90-compared-stelara-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-first-il-17a-antagonist-cosentyxtm-secukinumab-moderate-severe-plaque-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder-1 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nine-new-analyses-show-novartis-lcz696-could-change-course-heart-failure-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-first-il-17a-phase-iii-results-show-ain457-secukinumab-significantly-improves-psoriatic-arthritis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ain457-secukinumab-showed-significant-symptom-improvement-two-pivotal-phase-iii-ankylosing-spondylitis-studies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-present-first-il-17a-phase-iii-data-ain457-secukinumab-psoriatic-arthritis-and-ankylosing-spondylitis-acr-2014-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-multiple-sclerosis-advocate-and-musician-david-osmond-launch-ms-education-initiative-our-voice-songtm-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-advisory-committee-unanimously-recommends-approval-ain457-secukinumab-patients-moderate-severe-plaque-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-ctl019-data-published-nejm-demonstrating-efficacy-certain-patients-acute-lymphoblastic-leukemia-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-first-treatment-advanced-pancreatic-net-provide-overall-survival-more-35-years-phase-iii-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-cut-cardiovascular-deaths-20-vs-ace-inhibitor-landmark-paradigm-hf-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-showcase-heart-failure-leadership-esc-congress-2014-results-new-first-its-type-medicine-lcz696-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-two-pivotal-phase-iii-secukinumab-studies-demonstrating-statistically-significant-skin-clearance-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-personalized-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/pivotal-data-novartis-investigational-compound-lde225-show-marked-tumor-responses-advanced-basal-cell-carcinoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-key-advances-cancer-research-asco-and-eha-from-four-new-pivotal-studies-lung-blood-and-skin-cancers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-lar-shows-superior-efficacy-acromegaly-patients-not-controlled-first-generation-somatostatin-analogues-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-new-phase-iii-data-showing-secukinumab-ain457-improved-moderate-severe-plaque-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-stands-behind-medication-adherence-activities-and-reaffirms-commitment-patient-safety-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-hosts-competition-create-novel-mobile-solutions-heart-failure-caregivers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-data-effects-investigational-rlx030-kidney-blood-flow-chronic-heart-failure-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-exelon-patch-now-fda-approved-treat-patients-across-all-stages-alzheimers-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-novartis-team-inspire-people-ms-through-innovative-tandem-cycling-campaign-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/relapsing-ms-patients-more-satisfied-novartis-oral-drug-gilenya-standard-injectable-therapies-according-new-study-results-cmsc-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-findings-advancing-care-patients-170-abstracts-breast-lung-and-blood-cancers-asco-and-eha-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-disputes-allegations-two-us-government-lawsuits-and-looks-forward-fair-discussion-facts-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-tobi-podhalertm-certain-cystic-fibrosis-patients-first-and-only-dry-powder-inhaled-antibacterial-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-drug-gilenya-significantly-reduced-rate-brain-volume-loss-across-three-large-phase-iii-studies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-omalizumab-significantly-improved-chronic-idiopathic-urticaria-symptoms-patients-who-failed-standard-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-zortress-first-over-decade-approved-fda-prevent-organ-rejection-adult-liver-transplant-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-exjade-first-treatment-approved-fda-chronic-iron-overload-patients-non-transfusion-dependent-thalassemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nejm-published-study-shows-novartis-compound-acz885-significantly-relieves-symptoms-patients-serious-form-childhood-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/leeza-gibbons-joins-novartis-improve-caregiving-experience-millions-americans-through-real-world-peer-advice-alzheimersdiseasecom-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-emprende-una-campana-de-educacion-de-la-comunidad-hispana-de-ee-uu-sobre-la-enfermedad-de-alzheimer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-embarks-alzheimers-disease-educational-effort-us-hispanic-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-approved-fda-patients-mild-moderate-alzheimers-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/npc-statement-comments-made-media-coverage-paycheck-fairness-act-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-professional-women-cyclists-join-novartis-raise-awareness-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-showed-statistically-significantly-less-decline-function-alzheimers-vs-lower-dose-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-extension-study-data-novartis-drug-gilenya-shows-patients-successfully-treated-7-years-relapsing-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-update-united-states-prescribing-information-ms-therapy-gilenya-following-fda-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-transplant-portfolio-hecoria-first-generic-tacrolimus-can-be-prescribed-brand-name-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/plaintiff-sales-representatives-and-novartis-pharmaceuticals-corporation-resolve-class-action-wage-and-hour-claims-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-study-exjade-shows-significant-reduction-iron-overload-patients-non-transfusion-dependent-thalassemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-novartis-phase-iii-studies-show-twice-many-ph-cml-patients-achieve-deeper-levels-response-tasigna-compared-gleevec-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-acz885-helped-substantially-reduce-steroid-use-45-patients-serious-form-childhood-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-helps-women-advanced-breast-cancer-live-significantly-longer-without-their-disease-progressing-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-shows-qti571-significantly-improved-walking-distance-patients-life-threatening-pulmonary-arterial-hypertension-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-effective-patients-non-cancerous-kidney-tumors-associated-tsc-phase-iii-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-showed-acz885-provided-substantial-symptom-relief-84-patients-most-serious-form-childhood-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-supplemental-new-drug-application-novartis-therapy-gilenyatm-include-data-showing-reduction-t1-lesions-ms-marker-disease-activity-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-shows-acz885-severe-gouty-arthritis-provided-better-pain-relief-and-reduced-risk-new-attacks-68-vs-steroid-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-phil-keoghan-host-amazing-race-raise-awareness-multiple-sclerosis-through-inspirational-national-bike-tour-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-afinitor-first-new-treatment-nearly-three-decades-patients-advanced-pancreatic-net-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-therapy-gilenyatm-reduced-risk-ms-disability-progression-regardless-treatment-history-or-disease-severity-new-analysis-shows-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-recommends-us-approval-novartis-once-daily-bronchodilator-qab149-copd-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-information-extavia-interferon-beta-1-b-patients-regarding-triad-groups-alcohol-prep-products-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-amturnidetm-triple-combination-pill-treat-high-blood-pressure-patients-uncontrolled-two-medications-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-surpass-gleevec-slowing-disease-progression-patients-newly-diagnosed-cml-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-restructuring-us-field-force-align-changing-product-portfolio-and-strategic-growth-priorities-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-stand-together-ad-campaign-provides-strength-support-and-important-resources-11-million-alzheimers-caregivers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/analysis-shows-novartis-drug-tobi-associated-reduced-mortality-cystic-fibrosis-patients-common-lung-infection-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-gilenyatm-novel-first-line-multiple-sclerosis-treatment-shown-significantly-reduce-relapses-and-delay-disability-progression-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-tekamlotm-single-pill-combination-aliskiren-and-amlodipine-treat-high-blood-pressure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-affiliate-novartis-strongly-disputes-claims-past-discrimination-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-prevails-medicaid-pricing-case-alabama-supreme-court-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-tekturna-hct-initial-treatment-patients-unlikely-achieve-their-blood-pressure-goals-single-agent-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-new-biological-therapy-ilaris-approved-us-treat-children-and-adults-caps-serious-life-long-auto-inflammatory-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-fda-approves-exforge-hct-only-high-blood-pressure-treatment-combine-three-medications-single-pill-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-gleevec-receives-us-approval-first-treatment-reduce-risk-cancer-returning-patients-gastrointestinal-stromal-tumors-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-novartis-vaccines-and-pta-battle-flu-public-health-vaccination-initiative-urges-families-lets-fight-flu-together-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-show-potential-imatinib-mesylate-tablets-treat-life-threatening-form-pulmonary-artery-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-combined-sandostatin-lar-depot-and-monotherapy-controls-growth-rare-pancreatic-neuroendocrine-tumors-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-granted-priority-review-us-based-potential-fill-unmet-medical-need-patients-advanced-kidney-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-appeal-judgment-alabama-pricing-case-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-higher-initial-dose-gleevec-achieved-better-early-responses-standard-dose-patients-chronic-myeloid-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-presented-asco-show-potential-rad001-enhance-efficacy-and-overcome-resistance-breast-cancer-treatments-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-major-independent-trial-demonstrates-significant-anticancer-benefit-zometa-women-early-stage-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-more-doubles-time-without-tumor-growth-after-failure-standard-treatment-patients-advanced-kidney-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/strength-and-innovation-novartis-oncology-products-and-pipeline-potential-improve-patient-treatment-demonstrated-more-170-abstracts-asco-annual-meeting-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-femara-helps-protect-against-return-breast-cancer-even-when-treatment-starts-several-years-after-completing-tamoxifen-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-and-photo-tekturna-hct-single-tablet-combination-tekturna-and-diuretic-receives-us-approval-treatment-high-blood-pressure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/photo-new-data-show-gleevec-halts-progression-advanced-stages-life-threatening-form-leukemia-sixth-year-treatment-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2005-release-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2004-release-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-significantly-reduced-risk-recurrence-25-across-broad-population-patients-early-breast-cancer-clinically-meaningful-benefit-was-consistent-across-subgroups 2024-03-04T06:49:58-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-five-year-data-disability-outcomes-and-safety-kesimpta-ofatumumab-people-living-relapsing-multiple-sclerosis 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-phase-iii-natalee-trial-meets-primary-endpoint-interim-analysis-demonstrating-clinically-meaningful-benefit-broad-population-patients-early-breast-cancer 2024-04-30T06:50:06-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-pivotal-phase-iii-apply-pnh-data-ash-demonstrating-investigational-oral-monotherapy-iptacopan-superiority-over-anti-c5 2024-01-25T07:04:35-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-iptacopan-provides-clinically-meaningful-increases-hemoglobin-levels-complement-inhibitor-naive-patients-pnh 2024-02-11T06:49:41-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-prolonged-pfs-benefit-pre-and-perimenopausal-patients-aggressive-hrher2-metastatic-breast-cancer-compared-chemotherapy 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-scientific-advances-kisqali-iptacopan-scemblix-and-ytb323-data-sabcs-and-ash 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-beacon-hope-through-alliances-historically-black-medical-schools-address-systemic-health-disparities 2023-12-14T06:50:05-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-novel-mechanism-action-shows-superior-long-term-efficacy-and-consistent-tolerability-96-week-follow-chronic-myeloid-leukemia-trial 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-premieres-powerful-new-docuseries-tribeca-festival-shine-light-debilitating-skin-disease 2024-04-14T06:49:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-fda-approves-expanded-indication-novartis-leqvio-inclisiran-include-treatment-adults-high-ldl-c-and-who-are-increased-risk-heart-disease 2024-04-16T09:49:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-strengthens-commitment-beacon-hope-initiative-engages-new-collaborators-support-clinical-trial-diversity-break-down-economic-and-education-barriers 2025-02-08T22:41:48-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-long-term-leqvio-inclisiran-data-demonstrating-consistent-efficacy-and-safety-beyond-six-years 2024-03-27T06:50:24-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-one-lot-sandimmune-oral-solution-cyclosporine-oral-solution-usp-100-mgml-due-crystallization 2023-12-28T13:35:07-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-cosentyx-first-intravenous-iv-formulation-interleukin-17a-antagonist-rheumatic-diseases 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvicto-shows-clinically-meaningful-and-highly-statistically-significant-rpfs-benefit-patients-psma-positive-metastatic-castration-resistant-prostate-cancer-pre-taxane-setting 2024-01-08T05:50:07-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-confirms-unconstrained-supply-pluvicto-and-continues-significantly-expand-number-treatment-centers 2023-10-26T17:47:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-cosentyx-first-new-biologic-treatment-option-hidradenitis-suppurativa-patients-nearly-decade 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-us-nationwide-recall-two-lots-sandimmune-oral-solution-cyclosporine-oral-solution-usp-100-mgml-due-crystallization 2023-12-04T06:36:01-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-fabhalta-iptacopan-offering-superior-hemoglobin-improvement-absence-transfusions-first-oral-monotherapy-adults-pnh 2023-12-06T00:35:53-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/latest-novartis-kisqali-natalee-analysis-reinforces-25-reduction-risk-recurrence-across-broad-population-patients-early-breast-cancer-supports-regulatory-submissions 2024-03-27T06:50:24-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-48-week-results-from-phase-iii-apply-pnh-trial-showing-sustained-efficacy-and-long-term-safety-fabhalta-iptacopan-adults-paroxysmal-nocturnal-hemoglobinuria-pnh 2023-12-10T20:05:58-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-production-pluvicto-addition-its-largest-and-most-advanced-radioligand-therapy-manufacturing-facility-indianapolis 2024-01-05T09:50:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-lutathera-significantly-reduced-risk-disease-progression-or-death-72-first-line-treatment-patients-advanced-gastroenteropancreatic-neuroendocrine-tumors 2024-01-19T10:19:32-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-xolair-omalizumab-first-and-only-medicine-children-and-adults-one-or-more-food-allergies 2024-02-16T11:34:40-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-england-journal-medicine-publishes-phase-iii-data-showing-xolair-omalizumab-significantly-reduced-allergic-reactions-across-multiple-foods-people-food-allergies 2024-02-25T14:04:54-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-plans-expand-its-us-based-manufacturing-and-rd-footprint-total-investment-23b-over-next-5-years 2025-10-23T03:37:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-opens-new-radioligand-therapy-manufacturing-facility-california-part-23b-us-expansion-plan 2025-11-10T10:28:31-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-plans-build-flagship-manufacturing-hub-north-carolina 2025-11-19T12:35:44-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-breaks-ground-flagship-manufacturing-hub-north-carolina 2025-12-15T03:31:37-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-us-government-reach-agreement-lowering-drug-prices-us 2025-12-19T14:35:39-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-add-radioligand-therapy-manufacturing-facility-winter-park-florida-fourth-us-serve-patients-and-advance-23-billion-investment 2026-01-09T10:32:25-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-breaks-ground-new-global-biomedical-research-center-san-diego-accelerate-drug-discovery 2026-02-06T12:03:31-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-build-new-radioligand-therapy-site-denton-texas-delivering-more-next-generation-treatments-patients 2026-02-25T07:05:41-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-expansion-community-health-programs-close-gaps-heart-disease-and-cancer-care-targeting-more-30-countries-2030 2026-04-09T01:20:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-malaria-treatment-coartem-baby-receives-who-prequalification-paving-way-greater-access-newborns-and-young-infants 2026-04-24T01:20:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-finalizes-us-manufacturing-and-rd-expansion-plan-seventh-new-facility 2026-04-30T07:03:44-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-breaks-ground-denton-texas-radioligand-therapy-site-construction-now-underway-across-all-new-us-facilities 2026-05-07T09:02:42-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-igan-data-new-england-journal-medicine-show-fabhalta-slowed-kidney-function-decline-493 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-early-symptom-relief-and-long-term-control-complex-skin-diseases-aad-2026 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-pediatric-patients-aged-12-moderate-severe-hidradenitis-suppurativa 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-real-world-data-reinforce-earlier-use-pluvicto-chemotherapy-metastatic-castration-resistant-prostate-cancer 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-rhapsido-remibrutinib-data-aaaai-showing-potential-beyond-chronic-spontaneous-urticaria-csu 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-remibrutinib-first-therapy-achieve-phase-iii-primary-endpoint-chronic-inducible-urticaria-cindu 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-vanrafia-phase-iii-data-support-slowing-kidney-function-decline-patients-iga-nephropathy 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nfl-greats-and-novartis-tackle-prostate-cancer-myths-super-bowl-lx-relax-its-blood-test 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-receives-fda-breakthrough-therapy-designation-sjogrens-disease 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-significantly-extends-disease-control-patients-immune-thrombocytopenia-only-four-once-monthly-doses 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/1-4-metastatic-breast-cancer-patients-treated-novartis-kisqali-remain-progression-free-beyond-4-years 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-underscore-pioneering-scientific-innovation-hematology-and-oncology-ash-and-sabcs 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-itvisma-only-gene-replacement-therapy-children-two-years-and-older-teens-and-adults-spinal-muscular-atrophy-sma 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-asn-kidney-week-and-aha-scientific-sessions-demonstrate-momentum-broad-crm-portfolio-and-pipeline 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-first-drug-reduce-disease-activity-and-patient-burden-sjogrens-disease-phase-iii-trials 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-showcases-significant-immunology-advancements-acr-congress-new-data-complex-autoimmune-diseases 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-meets-primary-and-all-secondary-endpoints-phase-iii-trial-patients-polymyalgia-rheumatica-pmr 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/psmaddition-data-show-novartis-pluvictotm-delays-progression-end-stage-prostate-cancer 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-5-year-natalee-data-demonstrate-28-reduction-risk-recurrence-broadest-early-breast-cancer-patient-population 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-fabhalta-iptacopan-meets-phase-iii-primary-endpoint-slows-kidney-function-decline-patients-iga-nephropathy-igan 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-rhapsido-remibrutinib-only-oral-targeted-btki-treatment-chronic-spontaneous-urticaria-csu 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launch-direct-patient-platform-cosentyx-secukinumab-us 2026-05-15T02:21:50-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-further-support-benefits-kesimpta-relapsing-ms-following-switch-from-oral-disease-modifying-therapies 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-phase-iii-trial-meets-primary-endpoint-itp-demonstrating-statistically-significant-improvement-time-treatment-failure 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-both-ianalumab-phase-iii-clinical-trials-met-primary-endpoint-patients-sjogrens-disease 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-twice-yearly-leqvio-inclisiran-receives-fda-approval-new-indication-enabling-first-line-use 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-provides-update-phase-iii-gcaptain-study-cosentyx-giant-cell-arteritis-gca 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-demonstrates-statistically-significant-and-clinically-meaningful-rpfs-benefit-patients-psma-positive-metastatic-hormone-sensitive-prostate-cancer 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reduces-risk-recurrence-younger-patients-early-breast-cancer-natalee-subgroup-analysis 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-asco-and-eha-showcase-momentum-pioneering-portfolio-promising-pipeline 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-accelerated-approval-vanrafia-atrasentan-first-and-only-selective-endothelin-receptor-antagonist-proteinuria-reduction-primary-iga-nephropathy-igan 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-radioligand-therapy-pluvicto-earlier-use-chemotherapy-psma-positive-metastatic-castration-resistant-prostate-cancer 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-present-new-data-aan-including-seven-year-disability-outcomes-and-safety-analysis-kesimpta-people-relapsing-multiple-sclerosis 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-third-fda-approval-oral-fabhalta-iptacopan-first-and-only-treatment-approved-c3-glomerulopathy-c3g 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-named-first-ever-corporate-pharmaceutical-partner-national-football-league 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-presentations-aaaai-and-aad-underscore-commitment-advancing-treatment-hidradenitis-suppurativa-hs-and-chronic-spontaneous-urticaria-csu 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-detection-game-changer-novartis-makes-bold-play-prioritize-breast-health-and-inspire-new-wave-breast-cancer-screenings 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-novartis-kisqali-natalee-data-show-durable-reduction-distant-recurrence-broad-population-patients-early-breast-cancer 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-data-novartis-scemblix-reinforce-superior-efficacy-favorable-safety-and-tolerability-profile-adults-newly-diagnosed-cml 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-96-week-results-from-phase-iii-scemblix-asc4first-trial-ash-and-late-breaking-analysis-from-phase-iii-kisqali-natalee-trial-sabcs 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-fda-approved-newly-diagnosed-cml-offering-superior-efficacy-and-favorable-safety-and-tolerability-profile 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-oral-fabhalta-iptacopan-sustained-clinically-meaningful-results-one-year-phase-iii-c3-glomerulopathy-c3g-trial 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ribociclib-kisqali-recognized-category-1-preferred-breast-cancer-adjuvant-treatment-nccn-clinical-practice-guidelines-oncology-nccn-guidelines 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-positive-chmp-opinion-kisqali-help-reduce-risk-recurrence-people-hrher2-early-breast-cancer 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-relapsing-ms-reinforce-benefits-kesimpta-first-line-and-switch-patients 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kisqali-reduce-risk-recurrence-people-hrher2-early-breast-cancer 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-deepening-benefit-new-analysis-reducing-risk-recurrence-285-broad-population-patients-early-breast-cancer 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-begins-construction-two-new-radioligand-therapy-facilities-us-expanding-its-world-class-rlt-manufacturing-and-supply-network 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-accelerated-approval-fabhalta-iptacopan-first-and-only-complement-inhibitor-reduction-proteinuria-primary-iga-nephropathy-igan 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-granted-fda-priority-review-treatment-adults-newly-diagnosed-cml 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-phase-iii-data-first-show-superior-efficacy-favorable-safety-and-tolerability-profile-vs-standard-care-tkis-adults-newly-diagnosed-cml 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/latest-analysis-novartis-natalee-study-shows-kisqali-reduces-risk-cancer-recurrence-early-breast-cancer-patients-high-risk-node-negative-disease 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-atrasentan-phase-iii-data-show-clinically-meaningful-proteinuria-reduction-further-advancing-companys-iga-nephropathy-igan-portfolio 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-latest-phase-iii-fabhalta-iptacopan-data-c3-glomerulopathy-c3g-showing-clinically-meaningful-and-statistically-significant-351-proteinuria-reduction-vs-placebo 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-pioneering-innovation-cml-data-from-scemblix-phase-iii-asc4first-study-newly-diagnosed-patients-asco-and-eha 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-radioligand-therapy-lutathera-fda-approved-first-medicine-specifically-pediatric-patients-gastroenteropancreatic-neuroendocrine-tumors 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kesimpta-six-year-efficacy-data-show-substantial-benefits-recently-diagnosed-treatment-naive-people-relapsing-multiple-sclerosis 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-fabhalta-iptacopan-data-show-clinically-meaningful-and-statistically-significant-proteinuria-reduction-383-versus-placebo-patients-iga-nephropathy-igan 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-early-addition-twice-yearly-leqvio-inclisiran-following-maximally-tolerated-statin-therapy-significantly-reduces-ldl-c-ascvd-patients-real-world-setting 2026-05-08T01:52:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/novartis-launches-new-preferred-firm-program-legal-services 2023-11-30T11:04:46-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-pharmaceuticals-corporation-novartis-statement-recall-outside-united-states-sandoz-generic-valsartan-and-sandoz-valsartan-and-hydrochlorothiazide-film-coated-tablets 2023-11-30T11:06:40-05:00 daily 1.0 https://www.novartis.com/us-en/news/form-483-posting-us-food-and-drug-administration-fda-novartis-statement 2023-11-30T11:05:56-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-provides-update-use-and-safety-beovu-patients-wet-amd 2023-12-01T19:32:25-05:00 daily 1.0 https://www.novartis.com/us-en/news/life-science-companies-and-bill-melinda-gates-foundation-joint-communique 2025-05-27T03:56:51-04:00 daily 1.0 https://www.novartis.com/us-en/news/beacon-hope-addressing-health-disparities-through-holistic-community-based-collective-action 2023-11-30T10:57:12-05:00 daily 1.0 https://www.novartis.com/us-en/news/updated-packaging-now-available-sandimmune-100-mg-blister-packages 2023-11-30T10:55:26-05:00 daily 1.0 https://www.novartis.com/us-en/news/new-policy-related-340b-program 2023-11-30T10:58:49-05:00 daily 1.0 https://www.novartis.com/us-en/news/notice-healthcare-providers-and-entities 2023-11-30T11:00:05-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-joins-accelerating-covid-19-therapeutic-interventions-and-vaccines-activ-initiative 2023-11-30T11:01:33-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-us-response-covid-19 2023-11-30T10:58:03-05:00 daily 1.0 https://www.novartis.com/us-en/news/corrective-action-certain-100-mg-sandimmune-and-neoral-blister-packages-us 2023-11-30T11:04:09-05:00 daily 1.0 https://www.novartis.com/us-en/news/highlighting-unmet-needs-hidradenitis-suppurativa-hs 2023-11-30T10:54:28-05:00 daily 1.0 https://www.novartis.com/us-en/news/collaborating-address-disparities-cancer-screening 2023-11-30T10:53:41-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-statement-maximum-fair-price-entresto 2024-08-15T09:31:53-04:00 daily 1.0 https://www.novartis.com/us-en/news/bringing-breakthroughs-more-patients 2025-09-29T14:20:08-04:00 daily 1.0 https://www.novartis.com/us-en/stories/mccourty-twins-friends-shine-spotlight-sickle-cell-disease 2022-03-29T09:28:04-04:00 daily 1.0 https://www.novartis.com/us-en/stories/sourcing-innovation-strategically 2023-04-11T13:47:12-04:00 daily 1.0 https://www.novartis.com/us-en/stories/word-street-what-cell-and-gene-therapy 2022-03-29T04:11:13-04:00 daily 1.0 https://www.novartis.com/us-en/stories/day-reflection-novartis 2023-04-11T13:45:43-04:00 daily 1.0 https://www.novartis.com/us-en/stories/shaping-future-sickle-cell-disease 2022-07-21T09:54:08-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-looks-brightest-academic-minds-reimagine-metastatic-breast-cancer-treatment 2023-04-11T13:53:19-04:00 daily 1.0 https://www.novartis.com/us-en/stories/working-together-novartis-fight-covid-19-and-help-people-need 2023-04-11T13:54:40-04:00 daily 1.0 https://www.novartis.com/us-en/stories/reimagining-healthcare-challenging-times-novartis-society-us-report-2020 2023-04-11T13:50:28-04:00 daily 1.0 https://www.novartis.com/us-en/stories/telemedicine-helping-patients-underserved-communities-access-quality-healthcare 2022-03-29T09:16:34-04:00 daily 1.0 https://www.novartis.com/us-en/stories/understanding-heart-health-inequities-during-black-history-month 2023-04-11T13:49:02-04:00 daily 1.0 https://www.novartis.com/us-en/stories/home-app-helps-patients-stay-engaged-and-adherent-vision-monitoring-remotely 2023-04-11T14:03:46-04:00 daily 1.0 https://www.novartis.com/us-en/stories/addressing-health-inequities-starts-looking-within 2023-04-11T14:00:47-04:00 daily 1.0 https://www.novartis.com/us-en/stories/learning-connecting-and-moving-forward-together 2022-03-29T09:36:09-04:00 daily 1.0 https://www.novartis.com/us-en/stories/know-facts-and-be-advocate-prostate-cancer-awareness-month 2023-09-15T10:46:41-04:00 daily 1.0 https://www.novartis.com/us-en/stories/remembering-mens-health-national-veterans-and-military-families-month 2023-11-14T02:29:35-05:00 daily 1.0 https://www.novartis.com/us-en/stories/associate-volunteers-help-make-2023-multicultural-teen-corporate-mentoring-program-success 2024-07-08T11:16:12-04:00 daily 1.0 https://www.novartis.com/us-en/stories/journey-compassion-from-pharmacy-oncology-sales 2024-07-29T15:34:15-04:00 daily 1.0 https://www.novartis.com/us-en/stories/negative-impact-ira-patient-access-innovative-treatments 2024-08-15T09:44:23-04:00 daily 1.0 https://www.novartis.com/us-en/stories/learning-from-experiences-chronic-myeloid-leukemia-cml-community 2026-01-09T12:08:52-05:00 daily 1.0 https://www.novartis.com/us-en/stories/advancing-prostate-cancer-care-a-bold-new-partnership-helping-patients 2025-02-18T09:01:25-05:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-joins-susan-g-komen-first-its-kind-breast-cancer-policy-coalition 2025-03-12T18:05:54-04:00 daily 1.0 https://www.novartis.com/us-en/stories/autoimmune-diseases-disproportionately-impact-women-heres-why-matters 2025-05-13T15:15:54-04:00 daily 1.0 https://www.novartis.com/us-en/stories/addressing-elevated-lipoproteina-importance-testing-risk-patients 2025-08-29T10:05:52-04:00 daily 1.0 https://www.novartis.com/us-en/stories/victor-bulto-time-100-health-summit-oncology 2025-05-23T09:13:10-04:00 daily 1.0 https://www.novartis.com/us-en/stories/how-were-reimagining-cancer-care-next-generation-patient 2025-05-21T11:56:15-04:00 daily 1.0 https://www.novartis.com/us-en/stories/garage-innovation-hub 2025-05-23T09:32:06-04:00 daily 1.0 https://www.novartis.com/us-en/stories/how-katy-patient-turned-advocate-found-her-purpose 2025-06-02T11:34:58-04:00 daily 1.0 https://www.novartis.com/us-en/stories/3-ways-were-innovating-advanced-prostate-cancer-care 2025-06-16T12:20:50-04:00 daily 1.0 https://www.novartis.com/us-en/stories/3-innovative-ways-were-reaching-patients-beyond-our-medicines 2025-06-24T11:26:21-04:00 daily 1.0 https://www.novartis.com/us-en/stories/living-with-sjogrens-disease-one-womans-story 2025-10-01T15:55:17-04:00 daily 1.0 https://www.novartis.com/us-en/stories/high-lipoprotein-a-patient-story 2025-08-07T10:01:24-04:00 daily 1.0 https://www.novartis.com/us-en/stories/take-5-reshema-kemps-polanco-novartis-cco 2025-08-29T09:56:58-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-biomedical-research-hub-san-diego-thierry-diagana 2025-09-10T06:24:14-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-san-diego-research-development-innovation 2025-08-25T15:55:25-04:00 daily 1.0 https://www.novartis.com/us-en/stories/what-are-genetically-targeted-technologies-gtts 2025-09-17T10:31:29-04:00 daily 1.0 https://www.novartis.com/us-en/stories/treating-CML-chronic-myeloid-leukemia 2026-01-27T13:35:01-05:00 daily 1.0 https://www.novartis.com/us-en/stories/advanced-prostate-cancer-social-worker-support 2025-09-17T11:11:54-04:00 daily 1.0 https://www.novartis.com/us-en/stories/five-questions-katie-mazuk-novartis-us-chief-patient-experience-officer 2025-10-20T10:31:14-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-breast-cancer-how-women-feel-breasts 2025-10-03T10:42:06-04:00 daily 1.0 https://www.novartis.com/us-en/stories/high-lipoproteina-explained-what-you-need-know-about-hidden-emerging-indicator-heart-disease 2025-10-09T15:13:20-04:00 daily 1.0 https://www.novartis.com/us-en/stories/how-to-bridge-care-gaps-prostate-cancer 2025-10-22T15:28:33-04:00 daily 1.0 https://www.novartis.com/us-en/stories/veteran-delivers-cancer-treatment-to-patients 2025-11-11T12:38:22-05:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-teen-mentoring-program-changing-lives 2025-11-07T09:39:41-05:00 daily 1.0 https://www.novartis.com/us-en/stories/five-questions-eden-wells-chief-insights-and-decision-science-officer-novartis-us 2025-11-13T15:44:09-05:00 daily 1.0 https://www.novartis.com/us-en/stories/community-health-meeting-people-where-they-are 2025-11-17T14:57:57-05:00 daily 1.0 https://www.novartis.com/us-en/stories/innovating-america-new-rlt-manufacturing-site 2026-01-15T14:22:04-05:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-north-carolina-manufacturing-expansion 2026-01-22T15:26:22-05:00 daily 1.0 https://www.novartis.com/us-en/stories/five-questions-des-creary-novartis-us-chief-customer-engagement-officer 2026-03-06T16:44:32-05:00 daily 1.0 https://www.novartis.com/us-en/stories/victor-bulto-and-thierry-diagana-named-2026-time100-health-list 2026-02-11T13:52:10-05:00 daily 1.0 https://www.novartis.com/us-en/stories/whats-next-neuroscience-drug-discovery-conversation-genetic-medicine-head-bryan-laffitte 2026-02-23T12:49:51-05:00 daily 1.0 https://www.novartis.com/us-en/stories/power-precision-using-ai-navigate-future-prostate-cancer-care 2026-02-24T12:35:09-05:00 daily 1.0 https://www.novartis.com/us-en/stories/could-we-end-preventable-heart-disease-our-lifetime-novartis-leaders-explore-time100-health-event 2026-03-11T10:18:39-04:00 daily 1.0 https://www.novartis.com/us-en/stories/future-treating-autoimmune-diseases-science-tech-patients-driving-progress 2026-03-31T16:41:45-04:00 daily 1.0 https://www.novartis.com/us-en/stories/susans-story-i-never-imagined-id-be-someone-who-had-heart-attack 2026-04-20T14:14:41-04:00 daily 1.0 https://www.novartis.com/us-en/stories/stroke-awareness-month-what-you-should-know-about-your-stroke-risk 2026-05-14T13:39:35-04:00 daily 1.0 https://www.novartis.com/us-en/stories/understanding-breast-cancer-recurrence-risk 2026-05-13T09:51:18-04:00 daily 1.0 https://www.novartis.com/us-en/careers/career-search/job/details/req-10042198-qc-analyst 2025-11-25T12:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10029164-rechtsreferendar-mwd-der-rechtsanwaltsstation-oder-im-pflichtwahlpraktikum 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10047858-product-manager-hf-en-alternance 2026-01-21T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10053326-maintenance-technician 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10054210-intern-finance 2025-11-01T08:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10054444-principal-clinical-data-scientist 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10058488-data-steward 2025-12-03T01:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10051889-senior-principal-clinical-data-scientist 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059989-sales-executive 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10050524-senior-clinical-data-scientist 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10060203-snr-specialists-data-science-ai-data-digital-it 2025-12-03T01:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10060406-snr-specialist-platform-services-data-digital-it 2025-11-01T08:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10060795-director-decision-science-cvm 2026-04-21T15:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10021772-lehre-mechatronik-mfd 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10021773-lehre-elektrotechnik-mfd 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064230-lehre-metalltechnik-mfd 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062668-genai-solution-architect 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064031-clinical-data-engineering-lead 2025-12-03T01:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063581-head-erc-china 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065561-early-talents 2025-11-13T13:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10056080-associate-rlt-lab-technician 2025-11-18T10:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066972-japan-program-head-oncology 2025-11-17T16:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067189-executive-assistant-coordinator 2025-11-18T13:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066857-vodja-inzeniringa-lokacije-mzd-site-engineering-head-mfd 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067285-vice-president-crm-product-management-lead 2026-04-02T21:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066861-senior-manager-field-capability-development-spanish-speaker 2026-02-13T08:32:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067260-executive-director-crm-product-strategy 2026-04-28T00:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061108-patient-safety-group-manager 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067047-manufacturing-science-technology-experts 2025-12-05T14:31:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067046-engineering-experts 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067049-supply-chain-experts 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067048-manufacturing-experts 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065531-technical-steward-mwd-de-de 2025-12-09T13:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10051988-banco-de-talentos-para-consultores-tecnicos-es-es 2025-12-09T13:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059703-banco-de-talentos-para-pessoas-com-deficiencia-pcd-es-es 2025-12-09T13:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061501-associate-qa-officer-operations-ja-jp 2026-04-21T01:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068652-senior-project-engineermanager-level 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067629-senior-expert-science-technology-iii-prd 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066763-validation-lead 2025-12-15T22:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066741-senior-principal-statistical-programmer 2025-12-16T17:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068862-quality-experts 2025-12-18T15:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068836-senior-global-gcppv-auditor 2025-12-19T11:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062245-director-integrated-field-insights-analytics 2026-01-20T05:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068777-project-qa-lead 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10047028-director-business-applications-ai-products 2026-03-24T18:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068829-production-lead-weekend-days 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068697-production-technician-weekend-nights 2026-01-07T06:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069051-head-corporate-comms 2026-01-07T08:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069282-material-coordinator 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069345-associate-director-statistical-programming 2026-01-09T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069343-senior-principal-statistical-programmer 2026-01-09T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069499-senior-principal-biostatistician 2026-01-13T16:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069438-kierownik-ds-kluczowych-klientow-kardiologia-wojewodztwo-lubelskie 2026-01-13T12:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068041-market-brands-manager 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066742-assoc-director-statistical-programming 2026-02-12T13:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065710-kierownik-ds-kluczowych-klientow-kardiologia-rybnik-czestochowa-kedzierzyn-kozle 2026-01-16T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066986-legal-intern 2026-04-28T13:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069927-senior-statistical-programmer 2026-01-20T02:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069927-senior-statistical-programmer-ja-jp 2026-01-20T02:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067812-customer-engagement-specialist-ru-ru 2026-01-20T13:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067194-manager-scientific-writing 2026-01-22T12:33:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065124-director-policy-ja-jp 2026-01-23T03:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069390-expert-science-technology-ii 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070032-learning-delivery-manager 2026-02-25T15:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070332-mechaniker-mfd 2026-04-08T14:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070063-buyer-mandarin-speaker-zh-cn 2026-01-29T02:34:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070180-maintenance-technician 2026-01-30T02:32:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068813-manager-scientific-writing 2026-01-30T10:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070390-principal-statistical-programmer 2026-01-30T13:33:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070553-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070639-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-de-de 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-es-es 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-ja-jp 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-nl-nl 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-ru-ru 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-tr-tr 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-zh-cn 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070666-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070932-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070616-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069506-director-crm-product-owner-3-positions 2026-02-11T17:31:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-de-de 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-es-es 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-ja-jp 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-nl-nl 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-ru-ru 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-tr-tr 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071101-brand-manager-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-zh-cn 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071230-logistics-lead 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070283-production-support-engineer-mfd 2026-02-11T06:32:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071317-engineer-automation 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology-de-de 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology-es-es 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology-ja-jp 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology-nl-nl 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology-ru-ru 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology-tr-tr 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology-zh-cn 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071049-kierownik-ds-kluczowych-klientow-kardiologia-wojewodztwo-mazowieckie 2026-02-05T17:32:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071371-key-account-manager-rlt-mazowieckie-podlaskie-lubelskie-swietokrzyskie-podkarpackie 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071460-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071479-brand-manager-ipa 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071397-process-improvement-manager-operational-excelence 2026-02-06T19:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059749-clinical-development-director-renal 2026-02-09T10:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10052215-senior-clinical-development-medical-director-renal 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065816-associate-director-web-analytics 2026-02-10T12:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-de-de 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-es-es 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-ja-jp 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-nl-nl 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-ru-ru 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-tr-tr 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-zh-cn 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070090-data-analytics-and-tool-manager 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071842-gaojiquyushichangjingli 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070330-supply-chain-dispatch-shipping-expert 2026-02-12T11:33:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-de-de 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-es-es 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-ja-jp 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-nl-nl 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-ru-ru 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-tr-tr 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-zh-cn 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071532-priloznosti-za-iskalce-prve-zaposlitve-v-novartisu-v-sloveniji 2026-02-13T11:33:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071791-clinical-operations-country-head-france 2026-02-16T18:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070456-record-report-sr-specialist-es-es 2026-02-17T15:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology-sl-si 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071882-specialist-upravljanja-kakovosti-za-podrocje-skladnosti-racunalniskih-sistemov-qa-ecompliance-specialist-mfd-sl-si 2026-03-12T10:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-sl-si 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072578-technical-transfer-lead-wmd 2026-02-23T12:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071967-qc-analyst 2026-03-17T14:31:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071466-head-neuromuscular-diseases-translational-medicine 2026-02-23T20:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072758-senior-study-leader 2026-02-25T10:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070086-technisch-operator-packaging-visco-elastics 2026-02-25T22:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069230-sr-procurement-ai-analytics-lead 2026-02-26T06:31:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10050992-betriebswerker-maschinenbediener-bereich-herstellung-3-schichten-mwd-wehr-deutschland 2026-02-26T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072568-global-it-category-ai-transformation-manager 2026-02-26T10:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072504-manufacturing-specialist-ja-jp 2026-04-14T10:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072292-site-quality-head-texas-ad-level 2026-02-26T23:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072294-site-quality-head-florida-ad-level 2026-02-26T23:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072492-senior-patent-attorney 2026-02-27T02:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065729-senior-expert-container-closure-integrity-mfd 2026-02-27T15:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072912-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-de-de 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-de-de 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-es-es 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-es-es 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-ja-jp 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-ja-jp 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-nl-nl 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-nl-nl 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-ru-ru 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-ru-ru 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-sl-si 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-sl-si 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-tr-tr 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-tr-tr 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-zh-cn 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-zh-cn 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065466-associate-director-biomedical-research-clinical-quality 2026-03-02T18:33:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10037580-sr-manager-executive-communications 2026-03-03T06:32:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-de-de 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-es-es 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-ja-jp 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-nl-nl 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-ru-ru 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-sl-si 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-tr-tr 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-zh-cn 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072986-medical-affairs-head 2026-03-03T12:33:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073059-senior-manager-market-platform-operations 2026-04-17T11:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10058909-ed-head-analytics-engineering 2026-03-03T19:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072800-ed-decision-science-renal-ta-and-us-portfolio-product-strategy 2026-03-03T22:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071116-head-new-product-international-china 2026-03-04T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073021-senior-medical-science-liaison-oncology 2026-03-05T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073238-career-opportunities-engineering 2026-03-04T14:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073147-early-clinical-development-physician-immunology 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-de-de 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-es-es 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-ja-jp 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-nl-nl 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-ru-ru 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-sl-si 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-tr-tr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-de-de 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-de-de 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-es-es 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-es-es 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-ja-jp 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-ja-jp 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-nl-nl 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-nl-nl 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-ru-ru 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-ru-ru 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-sl-si 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-sl-si 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-tr-tr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-tr-tr 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-zh-cn 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072860-executive-director-functional-ai-process-excellence-market-access 2026-03-05T23:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073074-senior-pipeline-manager 2026-03-24T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073054-senior-legal-counsel-business-operations-launch-and-activation 2026-04-07T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069900-manager-ai-innovation 2026-03-06T13:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073131-manager-project-management-web-experience 2026-03-06T15:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager-de-de 2026-03-09T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager 2026-03-09T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager-es-es 2026-03-09T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager-ja-jp 2026-03-09T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager-nl-nl 2026-03-09T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager-ru-ru 2026-03-09T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager-sl-si 2026-03-09T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager-tr-tr 2026-03-09T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager-zh-cn 2026-03-09T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073402-tablet-baskikapsul-operatoru-gecici 2026-05-07T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065812-manager-innovation-lab-ai 2026-03-10T13:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073178-trial-vendor-senior-manager 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063125-associate-director-change-delivery-and-operations 2026-03-10T19:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073365-senior-market-access-manager 2026-05-07T00:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073788-lab-equipment-senior-qc-specialist-ru-ru 2026-03-11T11:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073233-tehnolog-proizvodnega-inzeniringa-lokacije-mzd 2026-03-11T12:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064353-director-oncology-data-science-lmw 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073333-associate-director-marketing-program-governance 2026-03-12T03:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070715-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073675-vodja-itot-proizvodne-lokacije-mzd-itot-site-head-mfd 2026-03-12T14:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10047115-director-data-science 2026-04-14T18:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073458-director-future-field-engagement-strategy-metrics-incentives 2026-03-13T18:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073457-director-future-field-engagement-strategy-capabilities 2026-03-13T18:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073454-director-future-field-engagement-strategy-role-design 2026-03-13T18:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064533-manager-martech-product-analytics 2026-03-13T11:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073874-global-gmp-senior-quality-auditor 2026-05-11T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074087-ai-enterprise-security-architect 2026-03-13T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073919-maintenance-technician 2026-03-13T19:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074091-director-financial-controls-compliance-us 2026-03-13T20:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074046-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073130-data-analyst-marketing-automation-platforms 2026-03-16T05:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072747-senior-rd-counsel 2026-03-16T09:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073483-visji-ast-specialist-mzd 2026-03-16T16:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073481-ast-analitik-ii-mzd 2026-04-14T13:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073482-ast-specialist-iii-mzd 2026-03-16T16:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074182-messstellenverantwortlicher-mwd-schaftenau-tirol 2026-04-14T12:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071217-senior-expert-medical-device-analytical-representative-mfd 2026-04-01T07:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074210-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073136-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-04-10T08:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074212-field-product-specialist-cardiovascular-and-metabolism-hcm 2026-05-04T17:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065854-director-launch-excellence-strategy-1-2 2026-03-19T19:31:46+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073577-ultra-rare-disease-territory-account-specialist-denver-co 2026-05-07T20:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069505-ed-crm-product-owner-data-ai 2026-03-17T21:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067825-support-applicatif-outils-canaux-digitaux-en-alternance 2026-03-18T15:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073809-clinical-program-leader-senior-clinical-program-leader-translational-clinical-oncology-dual-posting 2026-03-18T15:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073513-director-nps-field-engagement-strategy-remote-multiple-positions 2026-03-18T17:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074022-director-oncology-translational-research 2026-03-18T16:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074009-associate-director-analytics-automation-reusability 2026-03-18T20:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073938-senior-principal-scientistassociate-director-pk-sciences-dual-level-posting 2026-03-18T22:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073939-principal-scientist-i-or-ii-pk-sciences-therapeutic-areas-dual-level-posting 2026-03-18T22:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-de-de 2026-03-19T10:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding 2026-03-19T10:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-es-es 2026-03-19T10:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-ja-jp 2026-03-19T10:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-nl-nl 2026-03-19T10:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-ru-ru 2026-03-19T10:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-sl-si 2026-03-19T10:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-tr-tr 2026-03-19T10:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-zh-cn 2026-03-19T10:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073940-director-nonclinical-safety-assessment-expert-multiple-therapeutic-areas 2026-03-24T19:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074183-country-head-customs-trade-compliance 2026-03-20T12:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074286-manufacturing-systems-expert 2026-05-04T20:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074088-portfolio-pathologist-anatomic 2026-03-20T15:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065908-senior-expert-science-technology-downstream-process-development 2026-05-07T14:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074105-medical-science-liaison-msl-onc-prostate-radioligand-therapies-ky-tn-and-wv-remote 2026-03-21T03:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology-fr-fr 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073444-stg-medical-lead-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-fr-fr 2026-03-21T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073928-engineering-lead-trd-rlt 2026-03-22T23:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager-de-de 2026-03-23T02:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager 2026-03-23T02:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager-es-es 2026-03-23T02:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager-fr-fr 2026-03-23T02:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager-ja-jp 2026-03-23T02:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager-nl-nl 2026-03-23T02:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager-ru-ru 2026-03-23T02:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager-sl-si 2026-03-23T02:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager-tr-tr 2026-03-23T02:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager-zh-cn 2026-03-23T02:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073743-manager-brand-medical-and-finance-data-enablement 2026-04-27T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074568-japan-program-manager-development-ja-jp 2026-03-23T06:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074218-projektni-vodja-zivljenskega-cikla-izdelka-ekspert-mzd-product-lifecycle-project-manager-expert-mfd-sl-si 2026-03-24T08:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073857-manager-oskrbovalne-verige-eso-mzd-manager-eso-supply-chain-mfd-sl-si 2026-03-24T08:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074636-recruitment-experience-partner-flex 2026-03-23T14:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072287-site-quality-head-mwd 2026-03-23T15:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074639-recruitment-experience-partner-flex 2026-03-23T16:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059478-executive-director-analytics-insights-decision-enablement 2026-05-08T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073248-associate-director-medical-information 2026-03-24T08:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074322-seniorprincipal-scientist-ii-bmd 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074585-ast-laboratorijski-analitik-v-bioloskih-ucinkovinah-menges-mzd 2026-03-24T14:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071367-central-monitor 2026-04-27T12:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073566-ultra-rare-disease-territory-account-specialist-miami-fl 2026-03-24T15:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074569-congress-and-digital-channel-partner 2026-04-22T18:30:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074363-director-product-strategy-value-realization 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074371-director-platform-enablement-4-positions 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074376-director-product-design-2-positions 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074503-maintenance-lead 2026-03-25T02:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive-de-de 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager-de-de 2026-03-25T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager 2026-03-25T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive-es-es 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager-es-es 2026-03-25T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive-fr-fr 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager-fr-fr 2026-03-25T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive-ja-jp 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager-ja-jp 2026-03-25T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive-nl-nl 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager-nl-nl 2026-03-25T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive-ru-ru 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager-ru-ru 2026-03-25T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive-sl-si 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager-sl-si 2026-03-25T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive-tr-tr 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager-tr-tr 2026-03-25T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive-zh-cn 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager-zh-cn 2026-03-25T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073726-associate-manager-scientific-writing 2026-03-25T07:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074791-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071691-technischer-produktionmitarbeiter-mwd-halle-saale-sachsen-anhalt 2026-05-13T10:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074716-legal-trainee-novartis-corporate-functions-de-de 2026-03-25T13:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072500-global-quality-controlanalytical-science-and-technology-head 2026-03-25T14:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074750-principal-scientist-adpkd-biology-lead-renal-research 2026-03-25T16:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074869-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager-fr-fr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074758-associate-director-itot-automation-engineer 2026-03-26T12:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074001-director-analytics-standards-impact-measurement 2026-03-26T14:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074007-director-analytics-infrastructure-pipeline-operations 2026-03-26T14:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070373-senior-expert-science-technology 2026-04-30T08:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074586-associate-director-web-operations 2026-04-07T19:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074790-senior-automation-engineer 2026-03-26T21:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074404-senior-automation-engineer-high-throughput-screening 2026-04-01T00:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072914-dam-librarian 2026-04-22T05:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074092-senior-technical-manager-drug-substance 2026-03-27T11:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074393-head-data-privacy-and-ai-europe-legal 2026-03-27T15:33:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074849-ed-functional-ai-process-excellence-ids 2026-03-27T16:33:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074448-facilities-management-lead 2026-03-27T16:33:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074769-cardiovascular-territory-account-specialist-boise 2026-03-27T21:33:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074969-global-clinical-operations-clinical-project-manager 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10058282-japan-program-clinical-head-crm 2026-03-30T05:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074346-ekspert-mednarodne-trgovine-mzd 2026-03-30T08:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074170-global-category-manager-marketing-agencies 2026-03-30T12:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074406-project-engineer 2026-04-02T12:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074450-head-design-construction-management 2026-03-30T14:33:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager-de-de 2026-03-30T19:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager 2026-03-30T19:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager-es-es 2026-03-30T19:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager-fr-fr 2026-03-30T19:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager-ja-jp 2026-03-30T19:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager-nl-nl 2026-03-30T19:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager-ru-ru 2026-03-30T19:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager-sl-si 2026-03-30T19:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager-tr-tr 2026-03-30T19:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager-zh-cn 2026-03-30T19:33:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070448-operations-specialist 2026-03-30T20:31:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074795-associate-director-cmc-competitive-intelligence-management 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074792-senior-expert-ii-tppm 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075173-biomarker-lead 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074446-manager-nabave-tretjih-dobaviteljev-mzd-supply-operations-manager-mfd 2026-03-31T11:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072571-junior-manufacturing-technician 2026-03-31T12:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073918-project-engineer-capex-lead-es-es 2026-03-31T16:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068634-medical-information-agent 2026-03-31T17:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075200-senior-international-trade-analyst 2026-04-01T06:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software-de-de 2026-04-01T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software 2026-04-01T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075252-head-enterprise-architecture-data-digital-it 2026-04-23T16:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software-es-es 2026-04-01T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software-fr-fr 2026-04-01T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software-ja-jp 2026-04-01T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software-nl-nl 2026-04-01T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software-ru-ru 2026-04-01T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software-sl-si 2026-04-01T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software-tr-tr 2026-04-01T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software-zh-cn 2026-04-01T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074367-director-crm-portfolio-management 2026-04-13T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073941-senior-principal-scientistassociate-director-pk-sciences 2026-04-01T22:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073942-principal-scientist-i-or-ii-pk-sciences-therapeutic-areas 2026-04-01T22:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074539-trd-qa-specialist 2026-04-01T22:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074537-trd-sr-qa-specialist 2026-04-01T22:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074613-executive-director-portfolio-product-strategy-theranostics 2026-04-08T15:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075145-china-head-se 2026-04-08T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068753-gxp-training-learning-business-partner-german-language-required 2026-04-09T14:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069844-facility-manager 2026-04-02T10:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075203-pks-associate-director 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074264-key-account-manager-neurology-immunology 2026-04-02T16:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074628-senior-expert-science-technology-downstream-process-modelling 2026-04-05T22:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075075-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075505-sr-brand-training-manager 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075317-global-category-manager-it-software 2026-04-07T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072955-qualified-person 2026-04-07T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074097-qa-operations-manager-qp 2026-04-07T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074240-ekspert-tehnologije-izdelkov-mzd 2026-04-07T13:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074522-vodja-oskrbe-proizvodnje-mzd-supply-chain-head-mfd 2026-04-07T16:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075344-head-tco-translational-clinical-oncology-china 2026-04-28T08:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075527-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-04-08T08:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074672-data-management-infrastructure-manager 2026-04-08T18:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075333-clinical-sciences-associate-director 2026-04-08T21:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075253-warehouse-logistics-operator 2026-04-09T03:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075513-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-04-09T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate-fr-fr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075309-quality-manager-pilot-plant 2026-04-10T13:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075555-process-engineer-sterile-filling-mwd 2026-04-09T12:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074813-shift-lead-ii 2026-04-09T12:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067434-process-technician-supply-management 2026-04-09T14:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074766-vp-medical-team-head-cardiovascular-and-metabolism-cvm 2026-04-09T18:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071285-hr-project-specialist-maseeraty-program 2026-04-30T12:30:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075248-quality-control-lead-microbiology-aseptic-processes 2026-04-10T09:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069404-enterprise-security-architect-data-security 2026-04-10T13:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075671-digital-operations-intern 2026-04-10T14:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075624-neuroscience-territory-account-specialist-rochester-1-2 2026-05-04T15:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075493-cardiovascular-territory-account-specialist-stockton-ca 2026-04-10T23:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager-de-de 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075519-global-clinical-operations-cra-manager 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager-es-es 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager-fr-fr 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager-fr-fr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager-ja-jp 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager-nl-nl 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager-ru-ru 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager-sl-si 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager-tr-tr 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager-zh-cn 2026-04-13T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075748-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-de-de 2026-04-13T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive 2026-04-13T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-es-es 2026-04-13T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-fr-fr 2026-04-13T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-ja-jp 2026-04-13T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-nl-nl 2026-04-13T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-ru-ru 2026-04-13T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-sl-si 2026-04-13T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-tr-tr 2026-04-13T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-zh-cn 2026-04-13T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075449-engineer-multidiscipline-ii-mfd-tehnolog-proizvodnega-inzeniringa-lokacije-mzd 2026-04-22T09:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075424-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-04-13T08:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075196-vodja-ekipe-za-mednarodno-trgovino-mzd 2026-04-13T15:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070168-medical-representative-immunology-ophthalmology-sma 2026-04-14T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance-fr-fr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services-fr-fr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074521-engineer-process-mfd 2026-04-14T08:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074530-maintenance-technician-es-es 2026-04-14T08:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075584-apac-operational-excellence-head-and-china-robotic-sourcing-advisor 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075591-specialist-upravljanja-kakovosti-skladnost-mzd 2026-04-14T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075587-specialist-data-science-ai-large-molecules-platform-mfd 2026-04-14T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074698-manufacturing-specialist 2026-04-14T10:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074702-rlt-qc-manager 2026-04-15T11:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075476-qa-compliance-specialist 2026-04-14T11:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075151-therapeutic-area-strategy-director-neuroscience 2026-04-14T11:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075152-therapeutic-area-strategy-director-neuroscience 2026-04-14T12:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075469-specialist-quality-operations 2026-04-14T13:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075210-pilot-plant-operator 2026-04-23T16:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075611-senior-legal-counsel 2026-04-14T18:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074370-director-crm-product-operations 2026-04-14T20:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075919-neuroscience-territory-account-specialist-los-angeles 2026-04-14T21:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074786-clinical-sciences-trial-leader 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074904-global-clinical-operations-portfolio-team-lead 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074785-senior-clinical-sciences-trial-leader 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074784-clinical-sciences-associate-director 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073741-tehnik-v-proizvodnji-bioloskih-ucinkovin-mzd 2026-04-15T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd-de-de 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd-es-es 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd-fr-fr 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076026-zhangaizhecaiyong-associate-general-affairsqiyuesheyuan-ja-jp 2026-04-17T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd-ja-jp 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd-nl-nl 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd-ru-ru 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd-sl-si 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd-tr-tr 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd-zh-cn 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075437-engineer-process-mfd 2026-04-15T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075465-quality-operations-partner-ast-specialist 2026-04-15T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074656-sr-project-engineer 2026-04-15T10:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075706-customer-insights-engagement-manager 2026-04-28T09:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075436-equipment-specialist-de-de 2026-04-15T12:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074961-project-engineer-inspection-packaging-and-material-handling 2026-04-15T12:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074587-znanstveni-svetovalec-v-tehnicnem-razvoju-mzd-senior-expert-science-technology-mfd 2026-04-15T12:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071370-lead-central-monitor 2026-04-15T14:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu-de-de 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu-de-de 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu-es-es 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu-es-es 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu-fr-fr 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu-fr-fr 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu-ja-jp 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu-ja-jp 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu-nl-nl 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu-nl-nl 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu-ru-ru 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu-ru-ru 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu-sl-si 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu-sl-si 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu-tr-tr 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu-tr-tr 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu-zh-cn 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu-zh-cn 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075051-qc-specialist-ii 2026-04-16T06:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076103-shift-lead-ii-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075881-supply-chain-manager-global-clinical-supply 2026-04-16T10:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075311-technicien-de-production-hf 2026-04-16T12:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075359-labortechniker-qc-analyst-il 2026-04-16T15:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075655-tehnik-proizvodnega-inzeniringa-mzd 2026-04-16T15:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075656-tehnik-proizvodnega-inzeniringa-mzd 2026-04-16T15:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075721-director-risk-assurance-partner 2026-04-16T16:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076190-key-account-manager-oncology-central-and-eastern-slovakia 2026-04-21T08:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074789-associate-director-tppm 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075525-elektrotechniker-instandhaltung-mfd-kundl-austria 2026-04-17T16:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner-de-de 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner-es-es 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner-fr-fr 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner-ja-jp 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner-nl-nl 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner-ru-ru 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner-sl-si 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner-tr-tr 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner-zh-cn 2026-04-17T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075892-tehnolog-proizvodnih-procesov-mzd 2026-04-17T11:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075619-senior-expert-risk-mgmt-control-strategy-medical-devices 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071393-supply-chain-consultant-vaga-afirmativa-pcd-pt-br 2026-04-17T15:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075925-bpa-sr-manager 2026-04-17T16:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075920-bpa-manager 2026-04-17T16:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072539-strategic-access-manager 2026-04-17T18:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075334-staff-project-engineer 2026-04-17T19:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074321-portfolio-account-specialist-immunology-perth 2026-04-20T00:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076245-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10055091-tehnik-v-proizvodnji-bioloskih-ucinkovin-mzd 2026-04-20T07:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076197-tehnik-v-proizvodnji-bioloskih-ucinkovin-mzd-sl-si 2026-04-22T12:30:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075683-ast-specialist-mzd 2026-04-20T09:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074699-validation-expert-mst 2026-04-20T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074699-validation-expert-mst-ja-jp 2026-04-20T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071210-qc-analyst-fr-fr 2026-04-20T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064681-global-regulatory-affairs-associate-director-cardio-metabolic 2026-04-20T16:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-de-de 2026-04-21T03:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli 2026-04-21T03:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-es-es 2026-04-21T03:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-fr-fr 2026-04-21T03:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-ja-jp 2026-04-21T03:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-nl-nl 2026-04-21T03:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-ru-ru 2026-04-21T03:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-sl-si 2026-04-21T03:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-tr-tr 2026-04-21T03:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076244-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-zh-cn 2026-04-21T03:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076276-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075569-associate-manager-scientific-writing-es-es 2026-04-21T08:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076198-specialist-mst 2026-05-04T06:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076045-operater-mzd-sl-si 2026-04-21T08:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head-de-de 2026-04-21T07:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head 2026-04-21T07:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head-es-es 2026-04-21T07:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head-fr-fr 2026-04-21T07:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head-ja-jp 2026-04-21T07:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head-nl-nl 2026-04-21T07:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head-ru-ru 2026-04-21T07:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head-sl-si 2026-04-21T07:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head-tr-tr 2026-04-21T07:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head-zh-cn 2026-04-21T07:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076113-elektrotechniker-instandhaltung-mfd-novartis-pharmaceutical-manufacturing-gmbh-kundl-austria 2026-04-21T08:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074385-qa-compliance-lead-mfd 2026-04-21T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076354-yangfanyiyaodaibiao-zh-cn 2026-04-21T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075339-real-estate-specialist-strategic-planning 2026-04-21T11:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075583-head-apac-indirect-categories-and-nocc-klprocurement 2026-05-04T12:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075628-mechatroniker 2026-04-21T12:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075578-channel-governance-program-manager 2026-04-21T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075784-head-legal-value-access 2026-04-21T16:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076235-executive-director-therapeutic-area-strategy-oncology-and-hematology 2026-04-21T17:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076087-recruitment-experience-partner-lead-flex-team 2026-04-21T18:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073704-director-data-strategy-value-delivery 2026-04-21T18:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067251-senior-manager-field-design-advisory 2026-04-22T08:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074844-process-expert-mfd-schaftenau-tirol 2026-04-22T08:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074219-itot-specialist-mfd-itot-spezialist-mwd 2026-04-22T09:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076048-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd 2026-04-22T10:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076145-benefits-manager-india-europe 2026-04-28T18:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074685-people-partner-team-lead 2026-04-22T18:30:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062691-associate-director-physics-team-leader-and-process-automation 2026-05-04T16:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075127-process-expert-fmd-de-de 2026-05-07T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075923-portfolio-strategy-and-partnership-head-china 2026-04-23T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074724-laboratorijski-analitik-mzd 2026-04-23T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075921-tm-china-strategy-planning-lead 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076383-tehnik-v-proizvodnji-bioloskih-ucinkovin-mzd-sl-si 2026-04-23T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076396-expert-science-technology-analytical-operationsraziskovalec-ekspert-v-tehnicnem-razvoju-mzd 2026-04-23T10:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076372-laboratorijski-analitik-mzd-sl-si 2026-04-23T10:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary-de-de 2026-04-23T11:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary 2026-04-23T11:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary-es-es 2026-04-23T11:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary-fr-fr 2026-04-23T11:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary-ja-jp 2026-04-23T11:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary-nl-nl 2026-04-23T11:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary-ru-ru 2026-04-23T11:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary-sl-si 2026-04-23T11:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary-tr-tr 2026-04-23T11:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary-zh-cn 2026-04-23T11:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076440-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd 2026-04-23T13:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076050-site-itot-ai-champion 2026-04-23T13:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070651-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076186-senior-utility-engineer 2026-04-23T18:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075338-qa-operations-associate-weekend-days 2026-04-23T19:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075337-qa-operations-associate-weekdays 2026-04-23T19:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075081-isotope-project-lead-associate-director-st 2026-04-23T22:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075486-head-engineering-texas-ad-level 2026-04-24T03:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075487-head-engineering-florida-ad-level 2026-04-24T03:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076403-people-partner-compliance-central-processes 2026-04-24T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations-de-de 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076381-mehanik-mzd 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations-es-es 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations-fr-fr 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations-ja-jp 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations-nl-nl 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations-ru-ru 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations-sl-si 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations-tr-tr 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations-zh-cn 2026-04-24T09:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076472-infrastructure-endpoint-protection-security-engineer 2026-04-24T11:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076294-tehnolog-proizvodnih-procesov-vodilni-mfd 2026-04-24T14:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075082-global-logistics-manager-mfd-globalni-vodja-logistike-mzd 2026-04-24T14:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075351-automation-engineer 2026-04-24T14:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076290-associate-director-cell-therapy-analytical-project-lead 2026-04-24T15:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076017-director-oncology-priority-accounts-southern-ca 2026-04-26T17:30:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager-de-de 2026-04-27T03:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager 2026-04-27T03:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager-es-es 2026-04-27T03:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager-fr-fr 2026-04-27T03:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager-ja-jp 2026-04-27T03:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager-nl-nl 2026-04-27T03:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager-ru-ru 2026-04-27T03:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager-sl-si 2026-04-27T03:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager-tr-tr 2026-04-27T03:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager-zh-cn 2026-04-27T03:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head-de-de 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head-es-es 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head-fr-fr 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076554-senior-global-program-regulatory-manager-japan-ja-jp 2026-04-28T03:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head-ja-jp 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head-nl-nl 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head-ru-ru 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head-sl-si 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head-tr-tr 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head-zh-cn 2026-04-27T08:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076712-warehouse-logistics-lead 2026-04-27T09:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075539-product-costing-asset-manager-ru-ru 2026-04-27T09:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076214-director-servicenow-solutions-delivery 2026-04-27T10:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc-de-de 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076439-infrastructure-endpoint-protection-security-engineer 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076632-msl-manager-hema 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc-es-es 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076551-assurance-qualite-hf-en-alternance-fr-fr 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc-fr-fr 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc-ja-jp 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc-nl-nl 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc-ru-ru 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc-sl-si 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc-tr-tr 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076725-yangfanyiyaodaibiaomr-intern-zh-cn 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc-zh-cn 2026-04-27T11:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076667-director-therapeutic-area-strategy-immunology 2026-04-27T14:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076236-director-therapeutic-area-strategy-immunology 2026-04-27T14:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074642-therapeutic-area-strategy-director-oncology-hematology 2026-04-27T19:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074747-therapeutic-area-strategy-director-oncology-hematology 2026-04-27T19:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075576-sterility-assurance-expert 2026-04-27T23:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076779-equipment-engineer-ii-zh-cn 2026-04-28T03:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076721-senior-expert-science-technology-analytical-expert 2026-04-28T06:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076046-strategic-value-access-manager 2026-04-29T08:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076293-senior-product-project-manager 2026-04-28T12:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072023-recruitment-business-partner-ddit 2026-04-28T13:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076684-director-therapeutic-area-strategy-crm 2026-04-28T14:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076215-director-therapeutic-area-strategy-crm 2026-04-28T14:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076573-medical-affairs-head-greece-cyprus-malta 2026-04-29T12:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076406-ed-us-business-development-and-licensing-commercial-mergers-integrations 2026-04-28T20:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076795-allergy-territory-account-specialist-northeast 2026-04-28T21:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076064-sso-site-partnership-manager-emea-cze 2026-04-28T21:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076501-ed-crm-product-owner 2026-04-28T21:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076004-study-start-associate-director 2026-04-28T21:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076846-neuroscience-territory-account-specialist-great-lakes 2026-04-28T22:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075607-manager 2026-04-29T05:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076833-bpa-manager 2026-04-29T06:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068551-senior-expert-engineering-packaging-design-manager 2026-04-29T08:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076681-it-sr-business-analyst-cdmo 2026-05-13T13:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075924-pk-director-linchuangyaolizongjian 2026-05-15T03:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074419-tehnik-v-proizvodnji-bioloskih-ucinkovin-mzd 2026-04-29T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076418-associate-director-downstream-process-development-gt-pd 2026-04-29T13:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076320-record-report-sr-specialist-es-es 2026-04-29T21:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076185-utility-engineer-iii 2026-04-30T02:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076497-project-manager-engineering 2026-04-30T03:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076496-sr-project-manager-engineering 2026-04-30T03:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075976-senior-manager-qualification 2026-04-30T05:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076450-specialist-kontrole-kakovosti-mzd 2026-04-30T06:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075597-senior-manager 2026-04-30T07:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076655-snr-spec-data-engineering-expert 2026-04-30T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076416-site-quality-head 2026-04-30T13:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075913-director-psl-established-medicines-portfolio 2026-04-30T17:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076871-allergy-territory-account-specialist-denver-lincoln 2026-04-30T18:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076275-head-neurodegeneration-translational-medicine 2026-04-30T20:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076384-financial-analyst 2026-04-30T21:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076797-medical-science-liaison-cardiovascular-south-texas-territory 2026-05-01T01:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076700-record-report-lead 2026-05-01T09:30:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075016-director-us-cardiovascular-metabolic-cvm-communications 2026-05-01T16:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077169-field-medical-lead 2026-05-04T03:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076085-qc-sample-management-technician 2026-05-02T17:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072541-director-customer-engagement-advisor-ethics-risk-compliance 2026-05-03T18:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076393-senior-expert-science-technology 2026-05-03T22:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075934-portfolio-account-specialist-vic-east 2026-05-04T02:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076616-analytics-insights-manager 2026-05-07T00:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074008-ad-market-engagement-governance 2026-05-04T06:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076519-operater-na-pripravisterilizaciji-ali-polnjenju-mzd-sl-si 2026-05-04T07:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074372-financial-controls-and-compliance-manager 2026-05-04T09:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068341-odgovorna-oseba-za-sproscanje-zdravil-na-trg-mzd-qp-mfd 2026-05-04T09:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd-de-de 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076844-bpa-senior-manager 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd-es-es 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd-fr-fr 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd-ja-jp 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd-nl-nl 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd-ru-ru 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd-sl-si 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd-tr-tr 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd-zh-cn 2026-05-04T11:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076784-responsable-relations-sociales-people-partner-hf 2026-05-04T13:30:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076259-dir-ddit-dev-regulatory-affairs 2026-05-04T14:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075637-executive-director-pricing-contracting-de-de 2026-05-04T16:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077062-executive-director-pricing-contracting 2026-05-04T16:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077065-executive-director-pricing-contracting 2026-05-04T16:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077029-translational-medicine-academy-fellow-pharmacokinetics-sciences-modeling-simulaton-de-de 2026-05-04T17:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076855-translational-medicine-academy-fellow-clinical-science-innovation-csi 2026-05-04T17:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077055-translational-medicine-academy-fellow-preclinical-safety-data-science 2026-05-04T17:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077246-translational-medicine-academy-fellow-biomarker-development-bmd-molecular-cellular-soluble-sciences-mcs 2026-05-05T12:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076845-translational-medicine-academy-fellow-biomarker-development-bmd-laboratory-excellence-operations-leo-fr-fr 2026-05-04T17:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077178-medical-representative-disease-area-specialist-cardiology 2026-05-04T19:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077179-medical-representative-disease-area-specialist-renal 2026-05-04T19:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077177-medical-representative-disease-area-specialist-cardiology 2026-05-04T19:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076880-director-data-science-agentic-ai 2026-05-04T20:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075844-director-data-science-agentic-ai 2026-05-04T20:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076410-senior-manager-regulatory-affairs-cmc 2026-05-04T22:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077047-customer-excellence-capability-building-manager 2026-05-05T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077241-medical-governance-evidence-operations-manager 2026-05-05T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077041-area-manager 2026-05-05T07:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065078-team-head-clinical-label-management 2026-05-05T08:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075413-customer-service-logistics-coordinator 2026-05-05T08:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073375-field-product-specialist-cardiovascular-and-metabolism-hn 2026-05-05T08:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077039-director-portfolio-scientific-communications 2026-05-05T10:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076949-director-portfolio-scientific-communications 2026-05-05T10:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075691-field-product-specialist-cardiovascular-hcm 2026-05-05T10:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075554-tehnolog-proizvodnih-procesov-mzd 2026-05-05T12:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077370-brand-manager 2026-05-05T13:30:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077052-manager-compliance 2026-05-05T15:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077282-neuroscience-territory-account-specialist-north-jersey 2026-05-05T16:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076689-cost-accounting-and-inventory-specialist 2026-05-05T18:31:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076801-record-report-sr-specialist 2026-05-05T20:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076589-senior-clinical-supply-project-lead 2026-05-05T20:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076792-principal-scientist-biotherapeutics-bioanalyst-bench-scientist 2026-05-05T20:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076800-record-report-sr-specialist 2026-05-05T20:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076894-expert-engineering-metrology 2026-05-05T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074631-associate-directorsenior-principal-scientist-pk-sciences-therapeutic-areas-dual-level-posting 2026-05-05T22:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074018-renal-rare-territory-account-specialist-jacksonville-fl 2026-05-05T22:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077287-radioligand-therapies-rlt-area-business-leader-northern-ca 2026-05-05T22:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063980-therapeutic-area-partner-immunology-dubai 2026-05-06T02:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli-de-de 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli-es-es 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli-ja-jp 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli-nl-nl 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli-ru-ru 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli-sl-si 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli-tr-tr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072514-senior-manager-data-science 2026-05-06T08:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076542-laboratorijski-analitik-mzd 2026-05-06T08:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077436-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076386-site-quality-head-changping 2026-05-07T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077430-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-06T10:31:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076867-rd-quality-lead 2026-05-06T12:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076926-gfmd-junior-strategist 2026-05-06T12:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069041-vodja-upravljanja-kakovosti-operacije-mzd-qa-operations-lead-mfd 2026-05-06T13:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077386-qc-officer 2026-05-06T13:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075289-global-program-safety-lead-rlt 2026-05-06T13:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077131-global-program-safety-lead-rlt 2026-05-06T13:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077296-operater-mzd 2026-05-06T14:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077130-global-program-safety-lead-rlt 2026-05-06T14:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075959-senior-associate-map-psds-governance 2026-05-06T14:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077149-associate-director-translational-medicine-expert-tm-clinical-pharmacology 2026-05-06T15:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077288-customer-service-supervisor-es-es 2026-05-06T15:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm-de-de 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077044-sales-marketing-head 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077075-pricing-access-contracting-manager 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077486-medical-field-and-customer-excellence-manager 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077144-commercial-portfolio-lead 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077150-customer-excellence-lead 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077156-project-coordinator-execution-excellence 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077153-data-analytics-platform-dap-manager 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077134-field-excellence-manager 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077048-sales-marketing-project-coordinator 2026-05-13T12:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077071-ta-access-strategy-manager 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077155-marketing-launch-excellence-manager 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073187-trial-vendor-associate-director 2026-05-06T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076886-scrum-master-ddit-usi-americas 2026-05-07T15:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm-es-es 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm-fr-fr 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm-ja-jp 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm-nl-nl 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm-ru-ru 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm-sl-si 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm-tr-tr 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm-zh-cn 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076656-imaging-operations-manager-clinical-studies 2026-05-13T15:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077280-specialist-manufacturing-technical-support 2026-05-06T19:30:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico-de-de 2026-05-06T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico 2026-05-06T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico-es-es 2026-05-06T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico-fr-fr 2026-05-06T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico-ja-jp 2026-05-06T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico-nl-nl 2026-05-06T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico-ru-ru 2026-05-06T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico-sl-si 2026-05-06T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico-tr-tr 2026-05-06T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico-zh-cn 2026-05-06T20:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076996-senior-manager-peer-peer-marketing-2-positions 2026-05-15T18:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075353-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-07T03:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-07T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account-de-de 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-07T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account-es-es 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-07T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-07T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account-ja-jp 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-07T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account-nl-nl 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-07T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account-ru-ru 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-07T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account-sl-si 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-07T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account-tr-tr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-07T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm-de-de 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm-es-es 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm-ja-jp 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm-nl-nl 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm-ru-ru 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm-sl-si 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm-tr-tr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-07T06:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077170-ast-specialist-mzd 2026-05-07T07:30:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077572-therapeutic-area-partner-oncology-omani-national 2026-05-07T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070493-associate-expert-science-technology 2026-05-07T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076817-product-owner-reporting-and-analytics 2026-05-07T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076931-operater-mzd-sl-si 2026-05-08T07:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077580-tartimgranulasyon-operatoru-gecici 2026-05-07T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077587-ambalaj-blisterlemekutulama-operatoru-gecici 2026-05-07T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077588-kaplama-operatoru-gecici 2026-05-07T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075310-associate-director-solution-delivery-veeva 2026-05-07T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075260-sr-specialist-ddit-dev-gco-platform-release-mgmt 2026-05-07T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076055-bpa-lead 2026-05-12T18:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077325-gsoc-senior-analyst 2026-05-07T11:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073893-raziskovalec-mst-mzd-scientist-mst-mfd-downstream-process 2026-05-07T12:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073902-raziskovalec-mst-mzd-scientist-mst-mfd-upstream-process 2026-05-07T12:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074172-senior-manager-operational-excellence 2026-05-07T13:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077475-execution-excellence-head 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076816-senior-director-advanced-analytics-platforms 2026-05-07T17:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077393-integrated-insights-manager 2026-05-07T21:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077391-field-excellence-head 2026-05-07T21:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076205-medical-director-gastroenterology-early-clinical-development 2026-05-07T19:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077152-medical-director-gastroenterology-early-clinical-development 2026-05-07T20:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076838-head-clinical-document-management-integrated-systems 2026-05-11T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076764-sso-study-start-manager 2026-05-07T20:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075820-marketing-value-and-access-capability-manager 2026-05-07T20:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076577-associate-director-translational-medicine-expert-tm-clinical-pharmacology 2026-05-07T20:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075906-qa-compliance-specialist 2026-05-07T21:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074861-process-engineer-iii 2026-05-08T01:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china-de-de 2026-05-08T04:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china 2026-05-08T04:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china-es-es 2026-05-08T04:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china-fr-fr 2026-05-08T04:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china-ja-jp 2026-05-08T04:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china-nl-nl 2026-05-08T04:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china-ru-ru 2026-05-08T04:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china-sl-si 2026-05-08T04:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china-tr-tr 2026-05-08T04:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china-zh-cn 2026-05-08T04:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075358-manager-bsi-consulting-program-management-program-managementpmo-focus 2026-05-08T06:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064204-senior-patent-litigation-paralegal 2026-05-08T12:32:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068945-associate-director-solution-delivery-manufacturing-execution-systems 2026-05-08T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074708-clinical-trial-supply-manager 2026-05-08T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu-de-de 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077198-qa-specialist-qms-support 2026-05-08T09:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075538-expert-scientific-writer 2026-05-08T09:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu-es-es 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu-fr-fr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu-ja-jp 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu-nl-nl 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu-ru-ru 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu-sl-si 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu-tr-tr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu-zh-cn 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073036-associate-director-reporting-transformation-ai-enablement 2026-05-08T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077192-data-lead-marketing-platform-ops-msm 2026-05-08T10:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077194-activation-lead-marketing-platform-operationsm 2026-05-08T11:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077193-manager-crm-marketing-platform-ops 2026-05-08T11:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077538-senior-principal-statistical-programmer 2026-05-08T11:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074603-warehouse-associate 2026-05-08T12:32:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077814-head-clinical-document-management-integrated-systems 2026-05-11T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077385-inzenir-zagonov-kvalifikacij-mfd 2026-05-08T13:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072414-gcp-compliance-manager-emea-hub 2026-05-08T13:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071235-qa-operations-specialist 2026-05-08T13:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077816-head-clinical-document-management-integrated-systems 2026-05-11T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-de-de 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076037-research-scientist-dna-encoded-chemical-libraries-del-80-100 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077297-ast-specialist 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077823-visji-ekspert-upravljanja-kakovosti-skladnost-mzd-regulatory-cmc-facilitator-mfd 2026-05-15T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075482-project-controller 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-es-es 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-fr-fr 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-ja-jp 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-nl-nl 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-ru-ru 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076808-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-sl-si 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-sl-si 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-tr-tr 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-zh-cn 2026-05-08T14:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076353-senior-supply-chain-lead 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-hematology-it-it 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073628-brand-manager-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072954-site-maintenance-technician-l-specialist-compounding-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074509-senior-brand-manager-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074691-key-account-executive-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074129-brand-manager-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074886-global-clinical-operations-study-start-manager-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074898-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074108-access-strategy-manager-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073745-product-expert-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/global-category-manager-it-software-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-09T08:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073536-qualified-person-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075425-study-start-clinical-research-associate-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075503-clinical-development-medical-manager-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075420-regulatory-affairs-cmc-manager-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075829-manager-br-clinical-quality-assurance-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075831-associate-director-quality-evaluations-integrations-and-external-services-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076049-medical-science-liaison-immu-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076052-medical-science-liaison-immu-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072653-people-partner-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076261-gaojidianshangjingli-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075658-senior-china-program-head-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076306-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074153-senior-qa-operations-expert-qualified-person-mfd-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074742-production-technician-temporary-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074926-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075053-head-strategy-operations-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074811-sso-associate-clinical-project-manager-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076613-tmdp-china-head-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076633-ma-manager-bc-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076518-mehanik-mzd-equipment-specialist-mfd-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077000-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076747-gaojidequjingli-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077328-therapeutic-area-head-immunology-neuroscience-and-crm-it-it 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077409-sales-marketing-head-immunology-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076891-medical-affairs-head-mexico-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077442-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077449-sr-manager-retail-national-key-account-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075817-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077560-senior-marketing-manager-crm-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077443-head-portfolio-strategy-ops-gdd-china-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077769-senior-marketing-manager-csu-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076704-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd-it-it 2026-05-08T16:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077511-neuroscience-territory-account-specialist-chicago-north-il-1-2 2026-05-08T17:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077508-neuroscience-territory-account-specialist-san-jose-ca-1-2 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077530-neuroscience-territory-account-specialist-san-antonio-tx 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076159-executive-director-therapeutic-area-strategy-oncology-and-hematology 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077542-neuroscience-territory-account-specialist-indianapolis-south-1-2 2026-05-08T18:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077289-manager-programs-and-system-training 2026-05-08T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077653-director-market-access-strategy-neuroscience 2026-05-08T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077667-director-nps-neuromuscular-program-strategy-management 2026-05-08T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077670-director-integrated-field-targeting-and-nba-rare-disease 2026-05-08T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077654-director-channel-pricing-strategy 2026-05-08T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077609-ad-neuromuscular-field-trainer 2026-05-08T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077643-associate-director-nps-neuromuscular-program-strategy-operations 2026-05-08T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077612-senior-administrative-assistant 2026-05-08T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077613-associate-director-business-performance-neuroscience 2026-05-08T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077616-associate-director-data-strategy-neuroscience 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077641-manager-enterprise-operations 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077642-associate-director-program-management-neuromuscular-remote 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077614-associate-director-market-research-neuroscience 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077664-exec-dir-product-strategy-lead-dm1 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077668-director-vendor-management-planning 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077676-director-heor-product-lead-neuroscience-2-openings 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077618-ad-market-access-strategy-neuroscience-multiple-positions 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077644-manager-nps-program-operations-management 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077646-associate-director-advanced-capabilities-lead 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077377-specialty-sales-consultant-hematology-toronto 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077615-associate-director-patient-and-provider-analytics-neuroscience 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077046-environmental-social-governance-reporting-lead 2026-05-08T20:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077669-director-novartis-patient-support-nps-enterprise-platform-management 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077636-ad-clinical-sciences 2026-05-08T22:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077645-ad-content-planning-standards 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077671-director-integrated-field-execution-effectiveness-neuroscience-rare-disease 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077663-exec-dir-product-strategy-lead-fshd 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077665-director-product-strategy-lead-dm1 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077678-director-business-excellence-lead-neuromuscular 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076413-analyst-psc-workforce-management 2026-05-08T21:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077679-director-crm-product-owner 2026-05-08T22:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076602-patient-coordinator-1-pc-1-multiple-positions 2026-05-08T22:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077661-director-medical-communications-lead-neuroscience 2026-05-08T22:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077617-associate-director-crm-product-owner 2026-05-08T22:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077655-regional-director-medical-science-liaison-neuroscience 2026-05-14T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077656-director-field-medical-trial-acceleration-neuroscience 2026-05-08T23:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077608-ad-field-nps-neuromuscular-training-lead-remote 2026-05-08T23:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076546-senior-nuclear-medicine-radiologist 2026-05-10T09:30:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077780-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077761-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076012-global-senior-director-sterility-assurance 2026-05-11T04:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075213-manager-patient-support-program 2026-05-11T04:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077792-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-11T04:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-11T04:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077033-senior-data-visualization-analytics 2026-05-11T07:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10021766-lehre-labortechnik-mfd 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076999-yangfanyiyaodaibiaomr-intern 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077797-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077455-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077472-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077468-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077860-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077437-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077866-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077431-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077448-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-11T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii-de-de 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology-de-de 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068211-associate-director-global-external-partner-management-medical-devices-combination-products-mfd 2026-05-11T10:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075185-people-services-solutions-lead 2026-05-11T10:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii-es-es 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology-es-es 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii-fr-fr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology-fr-fr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii-ja-jp 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology-ja-jp 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii-nl-nl 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology-nl-nl 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii-ru-ru 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology-ru-ru 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii-sl-si 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology-sl-si 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii-tr-tr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology-tr-tr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077783-expert-science-technology-iii-zh-cn 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077782-associate-director-science-technology-zh-cn 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061182-global-program-associate-director 2026-05-11T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076531-expert-science-technology 2026-05-11T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076730-associate-director-pv-qa-data-digital 2026-05-11T12:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076866-senior-expert-engineering-parenteral-packaging 2026-05-12T13:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075373-project-controller 2026-05-11T12:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074226-senior-analyst-content-analytics 2026-05-11T13:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076982-internal-audit-manager-audit-intelligence-enablement 2026-05-11T14:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076977-director-audit-intelligence-enablement 2026-05-11T14:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076979-senior-manager-audit-intelligence-enablement 2026-05-11T14:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077610-associate-director-field-execution-lead 2026-05-14T20:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076917-specialist-kontrole-kakovosti-v-bioanalitskem-laboratoriju-mzd 2026-05-11T15:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077531-neuroscience-territory-account-specialist-fort-worth-tx 2026-05-11T15:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077529-neuroscience-territory-account-specialist-oklahoma-city 2026-05-11T15:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076941-manufacturing-system-expert-pas-x-mfd 2026-05-11T18:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077476-associate-director-ai-platform-architect 2026-05-11T16:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077324-associate-director-ai-platform-architect-aws 2026-05-11T16:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077503-commercial-portfolio-associate 2026-05-11T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076663-site-itot-ai-champion 2026-05-11T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076486-vendor-start-manager-ecoa-translations 2026-05-11T19:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075902-senior-rd-legal-counsel-global-clinical-development-operations 2026-05-11T19:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077650-director-brand-lead-2-positions-neuromuscular-disease 2026-05-11T22:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077649-executive-director-marketing-strategy-dm1fshd 2026-05-11T22:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077627-ad-marketing-strategy-2-positions-myotonic-dystrophy 2026-05-11T23:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077652-director-brand-lead-duchenne-muscular-dystrophy 2026-05-11T23:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077630-ad-marketing-strategy-2-positions-duchenne-muscular-dystrophy 2026-05-11T23:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077625-content-compliance-manager 2026-05-11T23:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076166-executive-director-medical-team-leader-cardiovascular-pipeline-and-prevention 2026-05-11T23:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077766-pharmacy-intern 2026-05-12T04:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077767-pharmacy-intern 2026-05-12T04:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076575-associate-director-brand-medical-and-finance-enablement 2026-05-12T06:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate-de-de 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076916-laboratorijski-analitik-v-bioanalitskem-laboratoriju-mzd 2026-05-12T07:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076675-operater-mzd 2026-05-12T07:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076995-director-chemistry-scientific-due-diligence 2026-05-12T07:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate-es-es 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate-fr-fr 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate-it-it 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate-ja-jp 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate-nl-nl 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate-ru-ru 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate-sl-si 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate-tr-tr 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077895-global-clinical-operations-senior-clinical-research-associate-zh-cn 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078021-commercial-portfolio-head 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076270-manager-search-evaluation 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078028-therapeutic-area-head 2026-05-12T08:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077939-head-therapeutic-areas-oncology-hematology-immunology-crm-ns 2026-05-12T09:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078007-field-product-specialist-cardiovascular-ha-noi 2026-05-12T10:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075361-ast-expert 2026-05-12T11:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075346-vendor-alliance-lead-associate-director-cardiac-safety-and-respiratory-diagnostics 2026-05-13T15:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076424-senior-expert-drug-supply-process-chemist 2026-05-12T11:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-de-de 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074606-bpa-manager-development-units 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076841-specialist-za-podatkovno-znanost-ui-mdf-specialist-data-science-ai-mdf 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-es-es 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-fr-fr 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-it-it 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-ja-jp 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-nl-nl 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-ru-ru 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-sl-si 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-tr-tr 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-zh-cn 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077389-expert-engineering-automation-engineerinzenir-avtomatizacije 2026-05-12T13:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-fr-fr 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-it-it 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-ja-jp 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-nl-nl 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-ru-ru 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-sl-si 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-tr-tr 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077699-msl-neurosciences-zh-cn 2026-05-12T12:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077389-expert-engineering-automation-engineerinzenir-avtomatizacije 2026-05-12T13:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077771-visji-ekspert-za-oskrbo-zdravil-mzd-senior-expert-drug-supply-mfd 2026-05-12T13:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078044-pricing-and-commercial-portfolio-manager 2026-05-12T13:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077604-sso-clinical-project-manager-remote 2026-05-12T14:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076317-quality-control-technician 2026-05-12T14:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077343-senior-director-ai-platforms 2026-05-12T15:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077760-head-ai-technology-enablement 2026-05-12T15:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075837-ekspert-tehnologije-izdelkov 2026-05-12T15:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077141-dermatology-territory-account-specialist-cherry-hill 2026-05-12T16:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077411-manager-fair-market-value 2026-05-12T16:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077139-dermatology-area-business-leader-philadelphia 2026-05-12T16:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077138-dermatology-area-business-leader-new-york-city 2026-05-12T16:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077233-procurement-specialist 2026-05-12T16:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077322-associate-director-ai-solutions-architect 2026-05-12T17:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076648-director-visualization-platforms 2026-05-12T17:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077683-regulatory-affairs-manager 2026-05-12T18:31:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077465-assistant-manager-ra 2026-05-12T19:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077601-ot-automation-engineer 2026-05-12T19:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077451-data-steward 2026-05-12T19:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071483-head-qa-ops-and-compliance-associate-director-level 2026-05-12T20:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077987-allergy-territory-account-specialist-las-vegas-nv-fresno-ca 2026-05-12T22:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078017-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli-de-de 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077882-gaojidequjingli 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli-es-es 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli-fr-fr 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli-it-it 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli-ja-jp 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli-nl-nl 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli-ru-ru 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli-sl-si 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli-tr-tr 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075680-gaojiquyushichangjingli-zh-cn 2026-05-13T04:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072415-heart-failure-disease-area-partner-mansoura-daqahlia 2026-05-13T06:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076625-operater-mzd-v-proizvodnji-trdnih-izdelkov 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076181-executive-director-development-sciences 2026-05-13T08:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076615-senior-expert-science-and-technology-oligonucleotide 2026-05-13T08:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077603-senior-manager-field-operations 2026-05-13T10:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077606-senior-manager-field-operations 2026-05-13T10:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078035-pricing-access-contracting-manager 2026-05-13T10:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076193-clinical-operations-head-turkey-cluster 2026-05-13T11:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076806-itot-engineer 2026-05-13T11:31:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074555-senior-scientist-assay-development-screening 2026-05-13T12:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078004-global-regulatory-submission-manager 2026-05-13T13:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075441-qc-analyst-ii-mwd 2026-05-13T14:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077717-senior-scientific-writer-ii 2026-05-13T13:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077803-rd-quality-specialist 2026-05-13T13:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077362-postdoc-manufacturing-science-technology-mst 2026-05-13T13:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077454-post-doc-process-expert 2026-05-13T13:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078010-trade-and-contracts-governance-manager 2026-05-13T13:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076670-senior-manager-internal-audit-rd-and-strategy-growth 2026-05-13T14:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077712-director-integrated-field-insights-analytics-ns-rare-disease 2026-05-13T14:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074190-qc-analyst-i-labortechniker-mfd 2026-05-13T14:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076741-manager-internal-audit-rd-and-strategy-growth 2026-05-13T14:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077239-senior-manager-internal-audit 2026-05-13T14:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077262-senior-manager-internal-audit-tech-ops 2026-05-13T14:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076720-qc-analyst-ii-mwd-microbioanalytics-2-2-tagschichtmodell-moglich 2026-05-13T15:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077891-senior-marketing-manager 2026-05-13T16:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069176-executive-assistant 2026-05-13T16:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076479-threat-detection-response-senior-specialist 2026-05-13T16:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077060-internal-audit-associate-director-americas 2026-05-13T16:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076963-sr-spec-ddit-ops-itot-small-molecules 2026-05-13T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077757-itot-lead 2026-05-13T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078122-master-sales-representative 2026-05-13T21:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078101-director-value-evidence-lead 2026-05-14T01:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager-de-de 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager-es-es 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager-fr-fr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager-it-it 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager-ja-jp 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager-nl-nl 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager-ru-ru 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager-sl-si 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager-tr-tr 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078146-senior-district-manager-zh-cn 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078009-global-clinical-operations-senior-clinical-research-associate-de-de 2026-05-14T03:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077998-gaojidequjingli-de-de 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078009-global-clinical-operations-senior-clinical-research-associate 2026-05-14T03:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077998-gaojidequjingli 2026-05-17T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077998-gaojidequjingli-nl-nl 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078009-global-clinical-operations-senior-clinical-research-associate-ru-ru 2026-05-14T03:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077998-gaojidequjingli-ru-ru 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078009-global-clinical-operations-senior-clinical-research-associate-sl-si 2026-05-14T03:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077998-gaojidequjingli-sl-si 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078009-global-clinical-operations-senior-clinical-research-associate-tr-tr 2026-05-14T03:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077998-gaojidequjingli-tr-tr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078009-global-clinical-operations-senior-clinical-research-associate-zh-cn 2026-05-14T03:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077998-gaojidequjingli-zh-cn 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068854-regulatory-affairs-head-vietnam 2026-05-14T04:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077208-calibration-technician-hvac-mwd 2026-05-14T06:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074933-senior-clinical-trial-leader-translational-medicine 2026-05-14T07:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077893-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-14T07:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077857-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-14T07:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078026-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-14T07:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078008-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-14T07:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076907-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-14T07:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078011-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-14T07:30:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076935-senior-medical-safety-lead 2026-05-14T08:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078157-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu-de-de 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077306-private-market-access-lead 2026-05-14T09:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077299-commercial-portfolio-head 2026-05-14T09:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076161-manufacturing-specialist-es-es 2026-05-14T09:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu-es-es 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu-fr-fr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu-it-it 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu-ja-jp 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu-nl-nl 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu-ru-ru 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu-sl-si 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu-tr-tr 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078251-yangfanyiyaodaibiaomr-intern-zh-cn 2026-05-14T09:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078177-senior-brand-manager-immu-zh-cn 2026-05-17T23:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant-de-de 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076835-specialist-za-podatkovno-znanost-ui-mdf-specialist-data-science-ai-mdf 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076822-quality-operations-specialist 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant-es-es 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077074-global-finance-master-data-specialist-es-es 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant-fr-fr 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant-it-it 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant-ja-jp 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant-nl-nl 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant-ru-ru 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant-sl-si 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant-tr-tr 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077439-fra-accountant-zh-cn 2026-05-14T10:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078280-process-specialist 2026-05-14T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077225-specialist-mbr-designer 2026-05-14T11:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077274-sr-specialist-ddit-ies-cloud-engineering 2026-05-14T12:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077914-global-labelling-associate-director-content 2026-05-14T13:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075370-clinical-sciences-trial-leader 2026-05-14T13:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077916-global-labelling-manager-content 2026-05-14T13:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077912-global-labelling-director-content 2026-05-14T13:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077817-regulatory-affairs-associate-director-cmc 2026-05-14T13:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078054-inzenir-tehnicnih-storitev-mfd 2026-05-14T13:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078100-director-content-strategy-training 2026-05-14T13:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069577-global-customs-and-trade-compliance-lead-rlt-mfd 2026-05-14T14:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074595-recruitment-experience-partner-dach 2026-05-14T14:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078083-quality-assurance-officer 2026-05-14T14:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077151-clinical-program-leader-cpl 2026-05-14T14:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077237-junior-portfolio-manager 2026-05-14T15:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078001-senior-expert-science-technology-mass-spectrometry-gene-therapy-analytical-development-chemistry 2026-05-14T15:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077232-portfolio-manager 2026-05-14T15:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070356-medical-science-liaison-msl-onc-heme-chicago-il-remote 2026-05-14T16:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077336-senior-analyst-forecasting 2026-05-14T16:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077054-medical-science-liaison-solid-tumor-oh-wv-pa-territory 2026-05-14T16:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077719-medical-science-liaison-solid-tumor-nc-sc-ga-territory 2026-05-14T16:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077563-executive-assistant-psp-coordinator 2026-05-14T17:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078098-director-decision-science-product-lead-neuroscience-1-2-roles 2026-05-14T18:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077221-specialist-mbr-designer 2026-05-14T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078104-director-precision-medicine-data-science-ai 2026-05-14T22:31:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077947-omnichannel-engagement-manager 2026-05-14T21:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078106-director-strategy-operations-neuroscience 2026-05-14T21:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078306-director-forecasting-neuroscience 2026-05-14T21:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072033-recruitment-experience-partner-apma-flex 2026-05-15T02:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073468-director-marketing-strategy-car-t-immunology 2026-05-15T04:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077315-program-manager-ddit-pocf-asknovartis 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072563-senior-product-specialist 2026-05-15T05:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075809-clinical-research-associate-manager 2026-05-15T05:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068593-senior-analyst-deployment-gtm-analytics 2026-05-15T06:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-de-de 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077217-manager-international-coe 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077902-time-service-delivery-expert 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077599-senior-analyst-crm-data-integrations 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077602-senior-analyst-master-data-management-data-integrations 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077596-senior-analyst-bi-visualization-data-integrations 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077597-senior-analyst-brand-data-enablement-data-integrations 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072563-senior-product-specialist 2026-05-15T05:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075809-clinical-research-associate-manager 2026-05-15T05:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068593-senior-analyst-deployment-gtm-analytics 2026-05-15T06:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-de-de 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077217-manager-international-coe 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078063-awops-associate-acc 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077902-time-service-delivery-expert 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077599-senior-analyst-crm-data-integrations 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077602-senior-analyst-master-data-management-data-integrations 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077596-senior-analyst-bi-visualization-data-integrations 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077597-senior-analyst-brand-data-enablement-data-integrations 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078182-clinical-quality-assurance-program-lead-associate-director 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077742-clinical-quality-assurance-program-lead-associate-director 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077053-director-internal-audit-techops 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077600-senior-analysts-data-analytics-enablement-data-integrations 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-es-es 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-fr-fr 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-it-it 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-ja-jp 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-nl-nl 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-ru-ru 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-sl-si 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-tr-tr 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073737-qa-officer-operations-zh-cn 2026-05-15T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076593-associate-director-data-integrations 2026-05-15T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068929-senior-hematology-medical-science-liaison-riyadh 2026-05-15T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074835-assoc-dir-ddit-ies-hpc-infrastructure-sr-engineer 2026-05-15T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075328-head-talent-management-us 2026-05-15T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076839-sr-specialist-ddit-ies-cloud-engineering 2026-05-15T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078057-awops-associate-acc 2026-05-15T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076303-intern-supply-operations-lci 2026-05-15T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078058-awops-associate-acc 2026-05-15T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078059-awops-associate-acc 2026-05-15T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078064-awops-associate-acc 2026-05-15T11:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077589-head-people-partner-india 2026-05-15T12:31:46+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10074814-principal-scientist-iii-oncology 2026-05-15T12:31:46+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078378-ldc-deployment-manager-manufacturing 2026-05-15T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077171-senior-medical-information-manager-1 2026-05-15T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078368-communications-patient-engagement-partner-pep-manager 2026-05-15T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073588-ultra-rare-disease-territory-account-specialist-beverly-hills-ca 2026-05-15T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078211-quality-manager-ecompliance 2026-05-15T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078381-brand-manager 2026-05-15T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073801-specialist-quality-control-physical-chemistry 2026-05-15T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078384-sr-sales-representative 2026-05-15T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077915-mehanik-v-enoti-pakiranje-mzd 2026-05-15T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077546-senior-engineer-mst 2026-05-15T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078027-executive-director-clinical-data-technology-platforms 2026-05-15T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077906-operater-v-enoti-pakiranja-mzd 2026-05-15T14:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10077242-regional-director-medical-science-liaison-great-lakes-region 2026-05-15T15:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078318-customer-operations-manager-radioligand-therapy-rlt 2026-05-15T16:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078139-assoc-director-visualizationpower-bi 2026-05-15T15:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078321-senior-brand-manager-oncology 2026-05-15T16:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078232-patient-access-lead 2026-05-15T16:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota-de-de 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076507-principal-scientist-iisenior-principal-scientist-modeling-simulation-dual-level-posting 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076872-director-health-economics-and-outcomes-research-heor 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota-es-es 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota-fr-fr 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota-it-it 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota-ja-jp 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota-nl-nl 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota-ru-ru 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota-sl-si 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota-tr-tr 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076796-sales-representative-oncologia-bogota-zh-cn 2026-05-15T17:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078067-regulatory-affairs-senior-manager-cmc 2026-05-15T18:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10076973-medical-science-liaison-rheumatology-boston-ma-new-england-coastal 2026-05-15T18:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078376-sales-representative 2026-05-15T19:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072697-associate-director-heor-product-lead-2-positions 2026-05-15T19:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078236-rheumatology-institutional-specialist-miami 2026-05-15T19:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10075343-senior-medical-director-cvd 2026-05-15T20:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10078412-clinical-sciences-associate-director 2026-05-15T20:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062534-hr-business-partner-director-mexico-based-supporting-us-organization 2026-05-15T21:31:07+00:00 daily 0.5